Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.
First Nations and Inuit Health Branch (FNIHB) Clinical Practice Guidelines for Nurses in Primary Care
The content of this chapter was revised in October 2011
Mental health is a broad topic addressed in several First Nations and Inuit Health publications. This chapter contains the clinical assessment and management of mental health concerns. The values and the philosophy integral to mental health care, including community programs and cultural consideration for First Nations and Inuit communities, are not addressed in this chapter. However, the approach to mental health care can be found in regional community health manuals, the National Orientation Manual and other First Nations lead organizations and associations.
"A state of well-being in which an individual realizes his or her own abilities, can cope with the normal stresses of life, can work productively and is able to make a contribution to his or her community."Footnote 1 It is a balance between the mental, emotional, physical and spiritual healthFootnote 2 of an individual and positive community functioning.
There is some agreement in the literature that mental health is evident in the following personal characteristics:Footnote 3
The disparity between Aboriginal mental health and that of the rest of Canadians is of concern.Footnote 4,Footnote 5,Footnote 6
"A serious disturbance in thoughts, feelings and perceptions that is severe enough to affect day-to-day functioning."Footnote 7 A person with a mental illness may display some or all of the following behavioural characteristics:
In addition to the effects on the individual client, mental illness often affects the family.
Unlike the diagnosis of most physical disorders, diagnosis of a mental illness does not usually mean a specific cause can be identified.
"A lifelong journey to achieve wellness and balance of body, mind and spirit. Mental wellness includes self-esteem, personal dignity, cultural identity and connectedness in the presence of a harmonious physical, emotional, mental and spiritual wellness. Mental wellness must be defined in terms of the values and beliefs of Inuit and First Nations people."Footnote 8
Many social, environmental and economic factors can impact an individual's mental health. An increased likelihood of, more severe, and/or longer length of mental illness are associated with the following risk factors:
The following are protective factors for mental illness (for example, factors that decrease the risk of adverse outcomes if mental illness occurs, factors that counteract mental illness risk factors, factors that decrease the risk of developing mental illness) if they predate it:
For the Aboriginal population in particular: knowing how to live on the land, being connected to culture and traditional activities, being involved in the community and aware of the history of Aboriginal peoples in Canada are protective factors.Footnote 11
The purpose of mental health assessment is to provide specific information about a client's behaviour, thoughts and feelings and the relation of these factors to the client's background, experiences and present circumstances. It provides the database for describing, diagnosing and eventually treating concerns. The information may be gathered from direct interviews with the client or from material provided by relatives, friends, or referring agencies. The assessment should provide enough data to rule out a psychiatric emergency such as suicidality, homicidality, psychosis, drug intoxication or withdrawal.
Good communication skills are essential to provide mental health care. This includes ensuring that the privacy and confidentiality of a client is respected during client care while maintaining personal safety during all client encounters. For more information on communication, see "Communication" in the chapter, "Introduction to the Clinical Practice Guidelines."
One communication technique, the BATHE Model, helps develop a positive relationship with clients while also quickly screening for some mental health concerns. It can be used to elicit the chief concern and/or start an interview. It involves:Footnote 14
General description of the client:
If a client has difficulty stating this information, perform a more detailed cognitive screening (for example, Mini Mental Status Exam).
The following characteristics of each sign or symptom below, if present, should be elicited and explored:
Chief concern:
Use an open-ended question to find out what the client considers the chief concern and allow them time to disclose their perception of the problem.
Increase in feelings of:
Somatic changes:
Integrative patterns and client's perception of their relationship to:
Personal
Familial
Much of the clinical examination is based on observation throughout the history taking, but sometimes questions will need to be asked in order to complete the mental status examination.
Appearance
Behaviour
Speech
Mood and Affect
Thought ProcessesFootnote 15 (how client comes to a conclusion)
Thought Content
Perception
Cognition
Insight and Judgment
In order to rule out physiological conditions that may present as a mental health concern, a thorough head to toe physical examination, including weight and height, should be completed after the client's psychological symptoms started.
Identify strengths and problems.
Make provisional diagnosis.
Determine need for emergency actions:
Whenever possible, treatment goals should be identified and driven by clients as they are the ones who need to determine and prioritize what is most important for them to work toward, how they will do it, and in what time frame. These goals may be directly or indirectly related to their medical diagnosis. Agreement between the care provider and the client helps to facilitate progress toward them.
General interventions to support mental health care are described in the following documents:
Consultation with another mental health provider (for example, physician, nurse practitioner, clinical nurse specialist, psychiatrist, psychologist, counsellor, social worker, mental health/wellness worker) is most often required in mental health care. This helps to ensure the client is linked to the best nonpharmacologic, pharmacologic, and specialist resources. Clients with, suspected to have, or at risk for serious mental or emotional impairments, psychoses, bipolar disorder, suicide and substance abuse require referral to an appropriate specialist as they will likely require long-term treatment. This consultation should take place early and regularly thereafter so that the client has a team of care providers to help them and so that further referral can take place if warranted.
Links with mental health and chronic disease (if the concern may be related to difficulties coping with a chronic disease) resources in the community should be made with the client's permission. Community resources may include community mental health/wellness worker, Native Aboriginal Youth Suicide Prevention Strategy worker, Native Aboriginal Drug and Alcohol Program worker, Brighter Futures/Building Healthy Communities worker, Indian Residential Schools Resolution Health Support or Cultural Support worker, community health representative, family visitor from the Maternal Child Health program, community wellness worker, diabetes worker, Home and Community Care worker, other clients and/or families who have experienced the particular mental health concern and are willing to serve as resources to those affected.
The decision whether to treat the client on an outpatient basis or admit and/or evacuate the client to a hospital (voluntarily or involuntarily) depends on several factors. This decision must be made in consultation with a physician and/or psychiatrist. The following should be considered:
Whether the client enters hospital voluntarily or involuntarily, it is very important that the family be kept informed (if the client is capable and consents) of his or her progress and that they maintain close contact with the client as much as possible.
Legal requirements, including consulting and referring to a psychiatrist, must be met before a person can undergo psychiatric assessment and/or be hospitalized against his or her will. These requirements vary from one jurisdiction to another, so you must refer to and follow the appropriate mental health legislation for your province or territory (for example, Form 1 admission). In most cases there must be evidence of risk of physical harm to the client or others before an unwilling person can be admitted. The assessment and recommendation for admission of one or more physicians is required in all jurisdictions.
During follow-up care, caregivers need to determine whether the treatment has met the goals and expectations of both the client and caregiver. This helps determine whether the goals and treatment plan need to be revised.
A group of mental health conditions that have specific combinations of physical, emotional, and behavioural symptoms, including excessive anxiety, fear, panic, worry, avoidance, and compulsive rituals, in response to a perceived threat. An anxiety disorder can be distinguished from normal anxiety or worries by having symptoms that persist, are of a greater intensity than expected, and impair daily functioning (for example, occupational, social).
Early signs of an anxiety disorder include persistent behavioural inhibition (for example, shyness and avoidance of novelty). This along with risk factors listed below are linked to anxiety disorder development.
Specific types of anxiety disorders include:
The Diagnostic and Statistical Manual of Mental Disorders IV Text Revision (DSM IV TR) provides more specific criteria for the diagnosis of each anxiety disorder. The
criteria for each disorder can be found on-line.
Excessive stress, anxiety or worry lately? If so:
Symptoms can be in one or more of three clusters: emotional, physiologic, and cognitive.
A full physical exam should be completed as well, including:
Depending on the type of anxiety disorder, definitive treatment may involve psychotherapy, desensitization therapy and/or medications.
Consult physician:
Whatever treatments available, clients must be willing and motivated to try the treatment(s) they choose.
Cognitive behavioural therapy, done by a trained therapist or specialist, can be very effective in treating anxiety disorders. It can include education, skills training (for example, problem-solving, social skills, monitoring emotions), exposure therapy, cognitive restructuring, and relapse prevention. Psychotherapy is often not available, but video conferencing may be available in your community to provide this intervention. The therapy helps clients recognize when they are anxious and encourages them to practice problem-solving strategies. Referral to a therapist or specialist should be done in consultation with a physician.
Consult a physician regarding medication use in acute/severe situations. Short-term use of lorazepam (Ativan) is a common approach, but it does not resolve the cause of the anxiety.
lorazepam (Ativan), 0.5-1 mg PO bid to tid prn
Benzodiazepines, SSRIs, SNRIs, anticonvulsants, and occasionally atypical antipsychotics may each have a role, depending on the type of anxiety.
Medevac urgently if there is profound disturbance, if there are safety issues or if the client needs more definitive treatment urgently. The decision whether to treat the client on an outpatient basis or admit and/or evacuate the client to a hospital (voluntarily or involuntarily) depends on several factors. This decision must be made in consultation with a physician and/or psychiatrist. For further considerations, see Hospitalization and Client Evacuation and Involuntary Admission.
Arrange follow-up with a physician at next available visit for all but very severe cases.
A range of disorders with a measurable deficit in cognition in at least one area (for example, memory, aphasia, apraxia, agnosia, executive function) from previous levels of function. It includes mild cognitive impairment and dementia.
Mild cognitive impairment (MCI): at least area of cognitive deficit, but no impairment in activities of daily living. Clients do not have dementia, but are likely at an increased risk for dementia.
There are many different kinds of MCI. Amnestic MCI has memory impairment for age and education (objective and subjective complaint). These individuals are more likely to progress to Alzheimer disease and/or vascular dementia. Non-amnestic MCI has impairment in one area of cognitive functioning other than memory.
Dementia: syndrome of progressive impairment of memory and at least one other area of cognitive function (for example, aphasia, apraxia, agnosia, executive function) compared to previous levels of function. It is sufficient to interfere with normal activities (for example, work, relationships) and independence. It may be due to an underlying reversible or irreversible process, but other diagnoses (for example, delirium, psychiatric concern, brain or systemic disease) are not better explanations.
Alzheimer disease (60-80% of cases) progresses gradually with memory loss about recent events. Other cognitive deficits may be present, but language and visuospatial abilities are usually affected early. Executive function problems, apraxia, and behaviour changes occur later in the disease.
Vascular dementia (10-20% of cases) has early executive dysfunction, but little memory impairment early on. Symptoms start abruptly and usually have a stepwise decline. Physical examination may demonstrate prior stroke(s).
Mixed dementia is a combination of Alzheimer disease and vascular dementia.
Frontotemporal dementia usually presents at a younger age (less than 75) with early behaviour and personality changes, and nonfluent aphasia.
Dementia with Lewy bodies progresses gradually with fluctuating cognitive function, persistent visual hallucinations, and parkinsonian motor activity.
Parkinson's disease dementia is a common feature of Parkinson's disease (PD); presents after the development of other neurologic manifestations of PD while Lewy Body dementia develops before motor manifestations of parkinsonism.
Alcohol-related dementia, including Korsakoff's syndrome.
Normal pressure hydrocephalus with the triad of dementia, urinary incontinence and gait disturbance.
Elicit the history from the client, but it is just as important to elicit corroborating information from a caregiver, friend, or the family (informant).
The chronic cognitive dysfunction associated with dementia and MCI should be differentiated from the acute and fluctuating level of consciousness associated with delirium. Although dementia puts patients at higher risk for delirium, that is, the two are often associated, delirium may also result from a number of other underlying medical conditions. Delirium is, by definition, a reversible deficit of attention. It is recognized on history by fluctuating agitation or psychomotor slowing over a period of hours to days. Tools such as the "digit span" (recalling a series of digits, starting with 2, and increasing the length of the series, until unable to recall a series on two attempts) can be helpful in testing attention in patients in whom delirium is suspected. Delirious patients should not undergo further cognitive testing until their acute condition has resolved.
In order to help rule out an underlying medical condition, ask about the following:
The physical exam is directed by the differential diagnosis, as generated by the history. A full physical exam should be completed and must include the following:
Delirium, dementia and depression can be difficult to distinguish from each other. Depression in the elderly is often confused with dementia because of the accompanying apathy and associated cognitive difficulties.
Unless an underlying cause is obvious, blood should be drawn for the following tests to rule out potentially reversible conditions:
Other investigations will be driven by the history and presentation.
Management is ultimately driven by the diagnosis. Ensure medical conditions (for example, delirium) are diagnosed and treated. All clients should be screened and treated (by a physician) for vascular risk factors (for example, hypertension, diabetes).34
Consult a physician if client is in acute distress, if there are unexplained new neurologic symptoms or focal deficits, upon the initial suspicion that client has dementia, if there is acute onset of cognitive impairment, if there are rapidly progressing symptoms (neurologic or cognitive), or if there are risk factors for serious intracranial pathology (for example, anticoagulant medication, history of trauma, previous cancer).
If agitation or behavioural issues are the concern, manage according to guidelines under "Violent or Acutely Agitated Psychiatric Clients."
Other resources for clients and caregivers include:
If at all possible, do not medicate. In particular, avoid sedation and antipsychotics (for example, haloperidol), as it may cause falls, worsen symptoms of impairment, and/or cause severe deterioration/death in those with dementia.
Refer to a physician for pharmacologic treatment options:
Follow up regularly (for example, monthly or more often as necessary), preferably on a home visit, to enable you to assess client functioning, behaviour, and cognition in his or her own environment. Regularly monitor response to treatment and manage any new symptoms.
Arrange for all clients with non-urgent symptoms of MCI or dementia to see a physician at the next available visit. Further diagnostic testing and/or referral may be warranted.
After a diagnosis of MCI or for those with persistent cognitive concerns, ensure reassessment (cognitive and functional) by a physician in 1 year.
Medevac may be necessary for clients with potential underlying organic pathology or if the risk-safety assessment requires that the client be admitted to hospital. The decision whether to treat the client on an outpatient basis or admit and/or evacuate the client to a hospital (voluntarily or involuntarily) depends on several factors. This decision must be made in consultation with a physician and/or psychiatrist. For further considerations, see "Hospitalization and Client Evacuation" and "Involuntary Admission."
Refer clients and caregivers to occupational therapy, if available, for assistance with using aids to daily living and to help develop coping behaviours.
"Abuse of power to harm or control a person who was or is a family member."50 It includes actual or threatened physical (for example, hitting, stalking), verbal (for example, threatening, coercing, harassing), emotional, financial, and spiritual abuse, social isolation, sexual assault, and neglect. It affects the physical and mental health of the victims. Often violence is toward a female from a male family member, but anyone can be victimized (including children who witness abuse). Partners, whether married (or not), and/or living together (or not), are still considered family members.
An act that results in, or can result in, physical injury. Such acts include inflicting blows that cause bruising, striking with a hand or instrument, kicking, biting, burning, beating, throwing, rough handling, assaulting, using physical restraints, confining, shaking, and threatening to cause harm. Bruising is the most common form of physical injury reported due to spousal violence.52
Repeated verbal or nonverbal attacks or omissions that affect, or could affect dignity, self-esteem, confidence, and self-worth. Such acts or omissions may include rejecting, criticizing, isolating, confining, intimidating, blaming, terrorizing, ignoring, corrupting, excessive pressuring, or verbally abusing or assaulting (for example, threats, humiliation, ridicule, insults) are categories of emotional/psychosocial abuse when the behaviours are repeated. This form of abuse can include spiritual abuse. Examples of emotional/psychosocial abuse include locking someone in a closet, preventing an older adult from attending church, threatening to leave the relationship, controlling what another person does and who they see, damaging the other person's belongings, or yelling at another person. Put-downs and name-calling are the most common form of emotional abuse reported due to spousal violence.53
A non-deliberate failure to provide for basic physical, emotional, developmental, psychological, medical, and educational needs that results in, or may result in, harm to a person who cannot fully look after themself. This can include noncompliance with health care recommendations, withholding medical care, inadequate personal care, inadequate supervision, inadequate protection from environmental hazards, abandonment, withholding love or affection, lack of nurturing, and inadequate hygiene.
Acts involving an individual's money or property when that person does not know about it and/or does not consent to it. It includes withholding all finances, fraud, theft of money or belongings, misuse of funds, withholding means for daily living (including food, medications, and shelter and preventing one from working), and a misuse of power of attorney.
Information about sexual abuse is presented in the "Sexual Assault" section of the adult clinical guidelines.
Information about child maltreatment and child sexual abuse is presented in chapter 5, "Child Maltreatment" of the pediatric guidelines.
Maintain a high index of suspicion. Individuals are often reluctant to report abuse.
The following presentations raise suspicion of abuse:55
The evidence is unclear whether routinely screening all clients for domestic violence is effective to prevent abuse.58 However, the Registered Nurses Association of Ontario Best Practice Guideline on woman abuse59 and most victims of abuse support routine verbal screening. It significantly improves detection rates of exposure to violence and can allow the nurse to assist individuals that are potentially or actually being abused.
Consider verbally screening for family violence as part of a medical or psychological assessment when:
Interview and examine the client by herself or himself (unless accompanied by children under 3 only). The client will not feel free to talk or feel safe if the abuser is nearby. Allow the client to talk at their own pace and to openly state his/her feelings. Ask why they feel that way. Ask non-leading, non-judgmental and open-ended questions. Do not pressure. This may be the only chance the client has to disclose. Members of the family, boarding home staff or other caregivers should be interviewed separately.
Assure confidentiality, but educate about the limits of confidentiality in the presence of suspected abuse and that the encounter will be documented in his/her medical file.
Some screening tools have been developed for domestic violence, but none of the tools have well-established sensitivities and specificities.60
While taking the history, look for and document:
A complete family violence history includes the following information:
There are many potential differential diagnoses, including:
Consult a physician or nurse practitioner if the injuries require it (for example, need a medevac) and/or if referral to services is required.
If the client does not disclose abuse:
If the client discloses abuse:
Resources on family violence:
Include the following information in a clear, legible, objective documentation:
Do not use the words "denies" or "claims" as they are judgmental. Instead use "reports," "chooses," "declines," or "client states." Do not document conclusions or general statements.
Provide continual, ongoing medical and emotional support. For older adults, use frequent home visits to assess their safety.
Offer to refer to an agency or individual who can discuss options with the victim. A counsellor or social worker can assist the client to increase self-esteem and provide continued support. Refer to other resources if the client is interested. Refer to a physician if the medical condition of the client warrants it.
Family violence may be classified as child abuse if a pregnant woman is affected and/or a child witnesses a parent being abused. For information on reporting family violence when a child or fetus is involved, refer to chapter 5 of the pediatric guidelines titled "Child Maltreatment", under the "Management of Child Maltreatment" section.
An individual in or formerly in an intimate relationship or marriage aims to dominate and control the other individual. The repeated behaviours create fear and intimidate so that there is increasing isolation from others. The behaviours may be physical violence, psychological attacks, and/or financial abuse.
Aboriginal individuals are almost twice as likely as other Canadians to report being a victim of spousal violence, and females are more at risk of serious violence (for example, gun involvement, choking) than males. The majority of those who experience spousal violence also are victims of emotional and/or financial abuse.67 Aboriginal women are 8 times more likely to be killed by their partner than other Canadians. Lastly, many reports show that over half and up to 90% of Aboriginal women in some communities experience domestic violence.68 The numbers for men are slightly lower.69
In addition to those listed as risk factors under "Family Violence" above, risk factors include:
Behaviour of someone with an ongoing relationship of power or trust to and a duty toward (for example, caregiver in retirement home or client's home, friend, spouse, child) an older adult (in Canada > 65 years, but some consider First Nations > 55 years old) that causes actual or potential harm (for example, physical abuse, emotional/psychosocial abuse, neglect, and/or financial abuse) to the older adult.
Older adult females are more likely to be abused by family members than males. Older adult females are most often abused by a spouse or an adult child, whereas older adult males are most often abused by an adult child. However, abuse by an acquaintance or stranger is also common in this group, yet is not accounted for in the definition of elder abuse.73 The most frequent type of abuse is financial and emotional/psychosocial, followed by physical.74
Aboriginal elders experience higher levels of abuse than other Canadian older adults.75
In addition to those listed as risk factors under "Family Violence" above, risk factors include:
In addition to the items discussed under "Management" for family violence, the following considerations for elder abuse should be made:
Information about gang involvement is presented in chapter 19 "Adolescent Health" of the pediatric clinical guidelines.
A disturbance of mood, usually recurrent, in which a "high" (mania) or a "low" (depression) is experienced with a greater intensity and for a longer period than usual.76 The symptoms must cause significant distress and/or impair social, occupational or other functioning and must not be due to other physical or mental health disorders.
Unhappiness, fearfulness and hopelessness can also appear in the following conditions:
Bereavement is a reaction to losing a close relationship. Often the following are present:
Management of normal bereavement:
Supportive counselling, including:
Bipolar I disorder is defined as one or more manic or mixed episodes. Almost all clients also experience depression, but it is not required for the diagnosis. Bipolar I is equally prevalent in men and women.
Bipolar II disorder is defined as one or more major depressive episodes and at least one hypomanic episode. It is more likely to begin at a younger age, is more common in women and those with a strong family history, and has a higher risk of suicide.
Bipolar spectrum disorder includes other related mood disorders, but most are not recognized by the Diagnostic and Statistical Manual IV.
As with all mood disorders, the symptoms must cause significant distress and/or impair social, occupational or other functioning.
The Diagnostic and Statistical Manual IV describes manic episodes as lasting at least 1 week (less if the person requires hospitalization) and include a distinct period of a persistently elevated, expansive or irritable mood and at least 3 (4 if it is irritable mood) of the following during that time. They can be remembered with the mnemonic DIGFAST:84
Mania may include psychotic features, but only if they occur during mood episodes, that are either mood congruent (for example, consistent with typical mania themes) or mood incongruent (for example, persecutory delusions).
Hypomania is defined the same as a manic episode, but the symptoms are only present for at least 4 days and it is does not significantly impair functioning.
Mixed episodes are defined as the co-occurrence of a manic episode and a major depressive episode nearly every day for at least 1 week.
Rapid cycling is defined as 4 or more mood episodes in a year with full or partial remission for at least 2 months between episodes with similar symptoms or a switch from depression to mania or vice versa. This occurs in approximately 20% of those with bipolar disorder and is slightly more common in women.
Cyclothymia is defined as the alternation of hypomanic symptoms with mild depressive symptoms, often over at least 2 years; however, the symptoms do not meet the definition of manic, mixed, or major depressive episodes. Rarely are there periods without symptoms and the symptoms do not last more than 2 months at a time.
Between 1% and 2.4% of the general population has bipolar disorder, which generally starts between the ages of 14 and 24. If the disorder starts before age 19 then the individual is more likely to have significant disruptions in quality of life. Over 50% or 60% of those diagnosed with bipolar disorder have a first episode during childhood or adolescence.
The course of bipolar disorder is variable with relapses and remissions. Depressive symptoms occur more often than manic symptoms throughout the disorder.85
Individuals with bipolar disorder often have comorbid conditions. Up to half of those with bipolar disorder also experience substance abuse, suicidal behavior, and/or anxiety disorders.
Information specific to bipolar disorder in adolescents is presented in the "Adolescent Health" chapter of the pediatric clinical guidelines.
The manic client is usually coerced into attending a health care facility by family or police officers and is often hostile, agitated, and perhaps belligerent. The client will attempt to tone down their feelings and grandiosity in order to appear normal and will rationalize or deny symptomatic behaviour. The history presented by family or others should be given considerable weight in making a diagnosis and deciding about treatment and management.
If a client suspected of having or known to have bipolar disorder is agitated, rapidly assess for the following prior to management:86
Obtain the history from both the client and family or friends, if possible, as some clients believe that their hypomanic states are normal and not a concern (particularly if they are in a depression). Ask open-ended, non-leading, and general questions about mood and symptoms of depression and mania. Then ask about specific symptoms of depression and mania (for example, whether they have experienced the symptoms, and their duration in current and previous episodes).
Assess for:
Assess for the following physical and psychosocial findings. If the client is acutely agitated defer assessment until they are able to cooperate:
Rule out potential medical causes by doing a full assessment of the following:
A diagnosis of bipolar disorder requires initial and ongoing diagnostic tests. Consult a physician or nurse practitioner to establish the need for the following, unless the client will be starting lithium:87
CBC, fasting serum glucose, fasting lipid profile, electrolytes, liver function tests, creatinine, BUN, calcium, serum bilirubin, PT, PTT, urinalysis, urine toxicology screen for substance use, TSH, pregnancy test (if female), prolactin, EKG (if > 40 years or if indicated).
If possible, consult a physician before giving any medication. Consult a physician if the client is experiencing or has previously experienced manic or hypomanic symptoms, even in the absence of current or previous depression.
If in acute manic phase, treatment is usually difficult, trying, and stressful for everyone involved. Manic clients seldom have insight into the mood disturbance and feel great. They resent the need for treatment as it may bring them down from the "high" and hospitalization will place external controls on their movements.
The basis of management is sensitivity and firmness. Be sensitive to the fact that the client is frightened and will do almost anything to defend against attacks, whether real or imagined, on his or her self-esteem. Avoid reacting to the client's defensive assaults, recognize the source of the client's anger, be concerned, and respond calmly. Such a response will reassure the client that there is no need to fear counterattack by the professional. Firmness indicates to the client that external controls will be used if the client is unable to exercise restraint or is overwhelmed by impulses. The client may respond by testing the professional's determination.
In the initial stages of management, it is often necessary to employ the services of other staff or police officers, who would be capable of subduing and restraining the client. Do not hesitate to call for reinforcements if required (see "Violent or Acutely Agitated Psychiatric Clients").
Comorbid conditions must be treated as well as the bipolar disorder. During acute mania, the client should discontinue caffeine, alcohol, and any other substances used.
Comorbid conditions must be treated as well as the bipolar disorder. During acute mania, the client should discontinue caffeine, alcohol, and any other substances used.
If diagnosis is not clear, ask the client to keep a mood diary or calendar where they rate their mood from 1 (most depressed) to 10 (most high) every day over a period of time. This can help identify manic or hypomanic episodes.88
If stabilized, discuss and educate clients and family members about:
Medication is essential to control the disordered behaviour, to alleviate stress, and to treat the underlying disorder. Initial adjunctive treatment is to manage acute agitation:
lorazepam (Ativan), 1-2 mg SL/PO/IM
Consultation with a physician is required for all of the following medications:
In severe cases, neuroleptic tranquilizers may be necessary for short-term use until in hospital:
haloperidol (Haldol), 0.5-5 mg PO bid to tid prn OR 2-5 mg IM q4-8h prn
An antiparkinsonian agent may have to be added to counteract extrapyramidal side effects caused by the haloperidol.
Occasionally, high doses of medication fail to settle a highly agitated manic client. The client is in danger of physical collapse and/or may pose a danger to staff or other clients.
Discontinue any antidepressant therapy.
Treatment in acute mania should start or optimize therapy with lithium, anticonvulsants and/or atypical antipsychotic medications.
Long-term maintenance therapy depends on the type of bipolar disorder. This can help to prevent or dampen future manic attacks.
Before lithium therapy is started, the following baseline diagnostic tests should be done: CBC, electrolytes, renal, liver and thyroid function, electrocardiography (ECG).
Often bipolar disorder, particularly early in the disease (for example, in adolescents), is chronic and refractory to treatment. But it will often respond to the medications listed above.90
The Diagnostic and Statistical Manual of Mental Disorders IV Text Revision (DSM-IV-TR) provides the following criteria for diagnosis of a major depressive episode:99
Five (or more) symptoms present for the same 2-week period, representing a change from previous functioning and at least one of the symptoms is depressed mood (for example, sad or irritable) or loss of interest or pleasure in usual activities for most of the day nearly every day.
All of the symptoms are listed in the mnemonic SADIFACES:
S for Sleep (for example, insomnia, hypersomnia, early morning wakening)
A for Appetite (for example, increased or decreased) or weight loss (more than 5% or not meeting expected gains in children) or weight gain
D for Depressed mood (can be irritable in children and adolescents, such as aggression or antisocial behaviour); often worse in morning
I for loss of Interest (for example, apathy, boredom, change in grades, social withdrawal)
F for Fatigue
A for psychomotor Agitation or retardation (change in energy level)
C for decreased Concentration or indecisiveness
E for low self-Esteem or excessive guilt (feeling worthless, hopeless)
S for Suicidal/infanticidal/homicidal ideation or recurrent thoughts of death (including recent dangerous behaviours)
Symptoms must cause significant distress or impairment in social, occupational (for example, school) or home functioning. Symptoms are not due to another medical condition (for example, hypothyroidism), delusions, hallucinations, bipolar disorder, substances (for example, drug abuse), or bereavement.
A major depressive episode can be categorized as mild, moderate, or severe. Mild depression is characterized by 5-6 symptoms, mild symptom severity, and mild functional impairment or normal functioning but with substantial and unusual effort. Moderate depression is between mild and severe depression. Severe depression is characterized by most symptoms, severe symptom severity, and an observable disability. Symptoms of depression may vary by cultural background.
Major depressive disorder occurs when the client experiences one or more major depressive episodes. Major depressive disorder can have melancholic features (for example, mood that does not improve even temporarily, early morning awakening, severe weight loss) and/or psychotic features (for example, mood congruent delusions or hallucinations). Major depressive disorder affects 11% of Canadians at some point in their life,100 yet over 30% of First Nations adults (27.2% of youth) have experienced major depression.101,102
Seasonal affective disorder is a major depressive episode with regular onset and remission of symptoms within a particular season. It usually occurs in the fall and/or winter.
Postpartum depression is a major depressive episode occurring within 4 weeks postpartum where symptoms can last up to 1 year after delivery. It occurs in at least 10% of mothers and is not the postpartum blues that may occur within 4 days postpartum.103
Subsyndromal/minor depression occurs when the client has fewer symptoms (for example 2-4) or a shorter duration of symptoms than required for a major depressive episode. The client may have functional impairment similar to a major depressive episode.
Dysthymic disorder occurs when depressed mood is present for most of the day on the majority of days for at least 2 years. Symptom-free periods may occur, but do not last longer than 2 months.104 In addition, 2 or more of the following are present during this time: change in appetite, insomnia or hypersomnia, fatigue or low energy, low self-esteem, difficulty concentrating, and/or hopelessness. Symptoms are not as severe as those during a major depressive episode and there are no psychotic features. A major depressive episode may not occur during the first 2 years of dysthymia, yet half of those experience one at some time during their life.97 Significant functional impairment occurs due to the length of symptoms. It may be superimposed upon or secondary to chronic mental disorder, personality disorder or organic mental disorder. It occurs in approximately 4% of Canadians during their life.105 Aboriginal individuals living off reserve are 1.5 times more likely to have depression than those in the general population.106
Females are twice as likely to be diagnosed with depression as males, starting in adolescence.107 However, depression can occur at any age.
For specific information about depression in children and adolescents, see "Depression" in the pediatric guidelines.
Assess for risk factors as listed above. If any risk factors are present, systematically screen (for example, at 6-week postpartum visit or 2-month well baby visit) and then assess for a depressive disorder.
Screening
The easiest way to screen for depression is to ask:
If there is a "yes" answer to either one, a more detailed assessment is warranted.
Assessment
Standardized diagnostic aids can be used to assess for depressive symptoms, but an interview with the client and other key informants, if possible, is essential to investigate the DSM-IV-TR criteria. A diagnostic aid can help diagnose depression and track the client's response to treatment. Examples include:
Establish the onset of, duration of, and seasonal pattern of symptoms (for example, SADIFACES mnemonic above).
In addition to risk factors for depression and depressive symptoms, also assess:112,113
Older adults with depression may present by themselves concerned about memory loss, distractibility, and problems concentrating (also signs of dementia). They often demonstrate psychomotor retardation and show poor effort on psychological testing (for example, Mini Mental State Examination).107
Assess for:
Rule out potential medication causes by doing a full assessment of the following:
Consider ordering CBC, TSH, creatinine, electrolytes, an EKG, and liver function tests113 to rule out other potential causes of depressive symptoms.
A mother with postpartum depression and symptoms of psychosis and/or suicidal/infanticidal ideation should not be left alone.
The goals of acute (first 8-12 weeks) treatment are to reduce symptoms, prevent suicide, and improve functioning. During the maintenance phase (6-24 months) of treatment, the goal is to prevent recurrence of the symptoms, treat comorbid conditions, and to return to full functioning and quality of life.
Consult a physician for all depressed clients and/or if the client has attempted or has thoughts about suicide/homicide and/or has had psychotic symptoms.
Treatment plans need to be individualized, developed with the client, and consider the severity of depression and available resources. Treatment goals should be set for function at home, with peers, and at work/school. Family support is essential to help support the client's recovery process.
Discuss with the client the obligations of confidentiality and its limits. Talk to them about what might be helpful to share with their family and/or friends and, if they agree, how they think it would be best shared.Footnote 118 Arrange for the support and involvement of family members/friends in their care. Postpartum women and/or older adults may require additional help at home.
Educate the client and the family about the depressive disorder they have, its symptoms, its expected course (regular functioning within weeks or months of treatment), its prognosis, and management options. Some resources are:
Teach coping strategies to clients whose depression is related to loss and/or trauma. Encourage them to express some of their feelings associated with the event(s) (for example, journaling, poetry, music, talking to someone).Footnote 119
For depression concurrent with chronic disease, talk to the client about how they are coping with the disease. Provide education and support to help them to better manage the condition and improve their quality of life.
For mild depression, actively support the client. Recommend client self-management through regular exercise, sleep, nutrition, and leisure activities. Supportive counselling should be offered, as it helps to find solutions to problems they identify.
Light therapy is effective in treating seasonal depression. Light therapy, exercise, yoga, and omega-3 fatty acids can also be used along with psychotherapy or pharmacotherapy for mild to moderate non-seasonal depression.Footnote 120
Subsyndromal depression may be better treated with psychotherapy interventions than pharmacologic ones.Footnote 121
For moderate or severe depression, or if the client has other conditions (for example, anxiety disorder, substance use), the client will need pharmacotherapeutic treatment and/or psychotherapy. Psychoeducation, supportive counselling, client self-management, peer support, and regular monitoring are all supported treatments.
Psychotherapy (for example, cognitive behavioural therapy, psychodynamic therapy or interpersonal therapy) is effective for depression and dysthymic disorder. Psychodynamic and interpersonal therapy are effective and can help clients understand their relationships and decrease dysfunctional interpersonal behaviours. Cognitive behavioural therapy educates one on how to reformulate negative thoughts, how to identify and correct factors that make depression worse (for example, inactivity) and to learn problem-solving skills.
Evidence shows that a combination of medication and psychotherapy is more effective than either one alone.Footnote 122 Psychotherapy is often not available in small communities, but video conferencing may be available to provide this intervention. Other psychotherapy options that are evidence based and do not rely on the care provider to have experience with psychotherapy are to assign sections of the following books or programs and then have an appointment to discuss client progress.Footnote 123,Footnote 124
Educate about pharmacotherapy:
In many cases of depression (including during pregnancy and postpartum), medication is indicated, after the risks and benefits have been considered. Treatment usually begins with selective serotonin reuptake inhibitors (SSRI) antidepressants (for example, sertraline, citalopram) or serotonin norepinephrine reuptake inhibitors (SNRI) (for example, venlafaxine). However, medication should be individualized to the client's symptoms, comorbid conditions, previous response to antidepressants, and potential drug interactions. Consult a physician to order all of these medications.
The medication recommendations for treatment of dysthymic disorder do not differ from those for major depressive disorder.Footnote 127 However, the response is less predictable (for example, usually takes longer) and less complete than in major depressive disorder. If symptoms intensify, a trial of medication may be indicated, after a physician is consulted. A considerable proportion of dysthymic clients become psychologically dependent on their medications. Thus, medications should be used judiciously, and efforts should be made periodically to discontinue them.
SSRIs are the safest of the antidepressants if taken as an overdose.
Sleep medications are rarely indicated, except for short-term use, as insomnia secondary to depression usually responds to nighttime antidepressant medication.
Monitoring needs may vary but generally a client should be monitored weekly for the first month and then biweekly for the next month, or until improvement has been noted. Regular follow-up is important, to monitor progress and to offer encouragement and support.
Treatment efficacy should be examined 4 weeks after starting:
Monitor at least monthly for 6 months after full remission of symptoms. Assess medication efficacy, target symptoms (treatment goals), adverse reactions, and medication compliance. Once every 3 months during this period repeat the assessment of symptoms with a diagnostic aid as listed above. After this, regularly monitor for 6-24 months.Footnote 126 In particular, clients who have had depression as an adolescent should be routinely monitored.
Monitor all clients at each visit for goal achievement, change in depressive symptoms, functioning at home, work/school and socially, and for adverse events (for example, related to medication use, including suicidal ideation, agitation, mania, sexual dysfunction), even if the client is followed by a mental health professional. If on an SSRI/SNRI, monitor for increased agitation, irritability, or decreased sleep. If any concerns are present, consult with a physician as the dose may need to be decreased or the medication discontinued. A flow sheet to monitor depression is available on page 91 of the
GLAD-PC Toolkit.
Provide education to clients at each visit.
If only some improvement has been noted after all treatment options have been exhausted, explore medication adherence, comorbid disorders and ongoing concerns, and consider a referral to a mental health professional.
Most depressed and dysthymic clients can be managed on an outpatient basis. All clients should be referred to a physician or psychiatrist, regardless of severity.
The decision whether to treat the client on an outpatient basis or admit and/or evacuate the client to a hospital (voluntarily or involuntarily) depends on several factors. This decision must be made in consultation with a physician and/or psychiatrist. For further considerations, see "Hospitalization and Client Evacuation" and "Involuntary Admission."
Psychotherapy and psychoeducation have important roles in the management of depression. If resources are available, referral should be made by a physician.
Refer to a physician for follow-up as needed, especially if the client is on an antidepressant or there is no response to treatment after a reasonable trial. Links with mental health and/or chronic disease resources in the community are to be made.
A behaviour where "you bet or risk money or something of value to have a chance to win or gain money or something else of value."Footnote 131
As with substance use, gambling can become an addiction. The addiction can be a psychological dependence (for example, needed to cope with problems) and/or physiological dependence (for example, increased need to gamble more to get the same effects, physical withdrawal symptoms). Most individuals start by experimenting socially. Addiction is a habit where the person cannot stop gambling, even though they try to. They are preoccupied with gambling, and they continue to gamble even though they experience negative consequences.
Gambling is a problem when it:
Gambling can become a behavioural addiction and a problem for 5% of the Canadians who gamble. Those who have problem gambling have a preoccupation and impaired control (for example, they are unable to cut back even with serious negative consequences) related to gambling. Approximately 5% of males report a pathological gambling problem.Footnote 132 One study found 43% of Aboriginals to have significant problems with gambling,Footnote 133 often related to stressors, including the determinants of health.
Males are most likely to play sports lotteries and pools. Females are more likely to play lotteries and bingo.
The assessment for gambling problems includes the type of gambling involved in, frequency, time involved, amount gambled, reasons for gambling and perceptions of gambling activities (for example, luck, control), as well as the psychological and social harms, financial consequences and loss of control related to gambling behaviour.
In addition to gambling behaviours noted above, also assess:
Assess readiness to change and motivation to change on scales from 1 to 10.
Abstinence from gambling.
Psychosis can present as delusions, hallucinations, disorganized speech, bizarre behaviour, catatonia, withdrawal and social withdrawal.
The psychotic episode may be an accompanying symptom of an underlying psychiatric illness of which mania, depression, and schizophrenia are the most common. Other psychotic disorders include substance-induced psychotic disorder, delusional disorder, brief psychotic disorder, and schizoaffective disorder. About 3% of Canadians experience some kind of psychosis in their life.Footnote 143
The cause of psychoses is not known, although a number of causes are postulated. Family upbringing, social problems, and/or a "weak" character are not the cause. Use of psychoactive substances (for example, ecstasy, cocaine, LSD) can trigger a psychotic episode in persons predisposed to psychosis.
The information regarding the clinical assessment of a client with psychosis is the same as for a client with schizophrenia, see "History," "Physical Findings," "Differential Diagnosis," "Diagnostic Tests," and "Complications" under "Schizophrenia."
Outcomes are improved if psychosis is diagnosed early and treatment started promptly. With effective treatment most people recover and go into remission.
All areas of management for psychotic disorders are the same as for schizophrenia (the acute phase); refer to these topics under the appropriate "Management" subheader under "Schizophrenia."
Disturbance for at least 6 months (including prodromal and residual symptoms) of a person's life with an active phase of 2 or more characteristic symptoms present for a large amount of time in a 1-month period. Symptoms must cause significant distress or impairment in social, occupational (for example, school) or home functioning. Symptoms are not due to another medical condition (for example, hypothyroidism), substances (for example, drug abuse), medications, mood disorders, or schizoaffective disorder.
Schizophrenia is the most common chronic psychotic disorder, with 1% of Canadians affected. It occurs slightly more often in men than women. Onset is usually in adolescence or young adulthood, but some cases can occur after age 45. Women tend to demonstrate symptoms later than men, but have a better prognosis even though they have more comorbid conditions.
Psychosis (for example, a positive symptom present for any period of time) is a hallmark symptom for schizophrenia, but it is not required for diagnosis.
The condition may present with insidious onset, or onset may seem sudden, with acute psychosis starting rapidly; however, prodromal symptoms are often identified retrospectively.
The course can vary with schizophrenia, as 10% completely recover after the initial diagnosis; 33% have intermittent symptoms and impairment; and over half experience chronic symptoms and functional impairment, even if they receive appropriate treatment.Footnote 147
There are several types based on the predominant symptoms:
Genetic predisposition: A higher prevalence is noted among family members of people with schizophrenia, and there is a higher concordance rate in identical than fraternal twins.
Environmental influences (for example, developmental insult, biological and psychosocial stressors): A higher prevalence is noted with advanced paternal age; first and second trimester and birthing insults (for example virus exposure, anoxia); and psychoactive drug exposure as an adolescent.
The typical client will present in an excited, agitated state, often with fearfulness or hostility, hallucinations and delusions, confusion and disorganization or poverty in speech and thought, vigilance and over-activity, poor grooming and hygiene. Mood is often blunted.
Most individuals with psychosis/schizophrenia are aware of and are distressed by their symptoms, but may be reluctant to disclose them. Establish a therapeutic relationship and directly ask about signs and symptoms. Interview the client and as many other sources (for example, family, friends, care providers) who knew the client before the psychosis as possible, with the consent of the individual. Complete a full mental health history, ensuring the following topics are covered:
Symptoms that individuals may have include:
Symptoms are sustained or recurrent in schizophrenia.
Delusion -- fixed, false belief, even after evidence to the contrary is presented; not due to cultural or religious background. Types are:
Disorganized speech:
Hallucination -- perception in absence of external stimuli
Disorganized or catatonic behaviour:
Negative symptoms:
If an acute psychotic episode allows a safe assessment, complete a full clinical examination which includes a mental status examination, as detailed in the mental health assessment section of this chapter. In addition, assess for the following physical and psychosocial findings:
For a first episode of psychosis and upon consultation with a physician or a nurse practitioner: urine drug screen, TSH, electrolytes, fasting serum glucose, fasting lipids, CBC, BUN, creatinine, LFTs, serum blood alcohol level. Consider if hepatitis C, HIV and STI tests (syphilis included) are required. These tests should be repeated as indicated during the stable phase of schizophrenia.
Management differs depending on the phase of the illness. The management plan for each phase is described under the appropriate heading and labelled according to phase, if applicable.
Establish goals of treatment with the client and family members.
Acute Phase
Stabilization and Stable Phases
Consult a physician or psychiatrist upon initial assessment and before administering any medication, if the client is experiencing psychotic symptoms, and/or if the individual has early warning signs or prodromal phase symptoms and psychosis is a possibility, even if they have not had any psychotic symptoms or episodes. Consult if a client has not responded to treatment (for example, only partial recovery of symptoms or function after 6-8 weeks), have not adhered to medication, have had intolerable medication side effects, have substance abuse problems, and/or if they have suicidal or homicidal behaviours.
Develop a positive relationship with the client and family (given confidentiality is respected and/or the appropriate referrals and forms have been completed [for example, release of information]) and provide realistic hope and optimism. It is important that clients, families and caregivers be engaged in the treatment process. Crisis intervention services aim to build a therapeutic relationship including listening, acknowledging the client and family's experiences, curtailing self-blame and shame, taking the concern seriously, being supportive, decreasing anxiety, instilling hope, encouraging them to use this experience as an opportunity for growth, involving them in the development of a therapeutic plan, and using calm, clear, and simple communication. Crisis intervention aims to increase the client's level of social, occupational/educational, cognitive, and behavioural functioning.Footnote 152 Determine if the client is competent to accept treatment and give informed consent at each stage of treatment.
Acute Phase
Start by ensuring your own safety, the safety of other clients and staff, and the safety of the affected client. Establish firm control of the situation as soon as possible; it may entail the use of physical restraint as a last resort. In many instances, a show of force by numbers (for example, by having clinic staff, police, or security officers present) will settle the client sufficiently so that physical means of control need not be used.
Care must be taken to avoid exacerbating the situation by failing to give the excited client enough physical and psychological room (especially if he or she is suspicious or paranoid). The acutely psychotic or delirious client should be placed in a room that can be readily observed but that has minimal stimulation (for example, noise and light). Eye contact may be disturbing, as it may be interpreted as threatening or aggressive. Maintain a considerable physical distance to avoid being struck and also to appear less threatening to the frightened client. Questions asked should not be probing, and sensitive areas, if identifiable from previous background history, should be avoided. Delusion should not be challenged or supported.
If the excited, psychotic client appears on the verge of violence (to self or others) or escape, you should not obstruct the escape route or end up in an enclosed space alone with the client. It is preferable to allow the client to bolt than to risk being assaulted (see "Violent or Acutely Agitated Psychiatric Clients").
Educate clients, family and caregivers:
Family/caregiver interventions:
Stabilization Phase
Educate clients, family and caregivers:
Family/caregiver interventions:
Stable Phase
Advocate for a supported employment program or volunteer work which allows the client to work to their capacity, to gain vocational skills, and to work toward goals they have (paid employment).
Education (as in the previous stages) and cognitive behavioural therapy should continue and be reinforced during this phase.
Client Counselling
The client with schizophrenia will likely experience a number of stresses and problems directly or indirectly related to the disorder, for which personal counselling is desirable:
Initiate treatment as soon as possible, as there are effective treatments. Delays in treatment increase the risk for slower and less complete recovery, in addition to serious distress for the client (for example, depression, social isolation, poor family relationships, fear, confusion, suicide, declining school performance, poor self-esteem). Early treatment improves negative, cognitive and mood symptoms for at least 2 years.Footnote 147
Acute Phase
If the client is experiencing psychotic agitation and/or is violent, medication can be administered (see "Violent or Acutely Agitated Psychiatric Clients").
Antipsychotic medications are essential for treatment (acute and long term) and to alleviate symptoms in most people. They should be started as soon as possible. If clients have previously been on antipsychotics this should be noted along with their response, side effects and the client's preferred route of medication.
Consult a physician or psychiatrist before initiating any medication. Treatment is initiated with second-generation antipsychotics such as olanzapine and risperidone (preferred because of decreased side effects.) Often physicians start with a low dose and increase it slowly. Use of more than one antipsychotic at a time is not supported by evidence. Medications trials should last 4-6 weeks at the optimal dosage (some longer), as acute psychotic symptoms take this long to decrease. Generally it takes more than 2 months before the medication is fully effective.
If possible, before starting medications, do baseline ECG, complete blood count and liver function testing (LFT), as well as an assessment for any signs and symptoms of the antipsychotic side effects listed below.
Stabilization and Stable Phases
Most individuals with a first episode of psychosis will achieve remission of the positive psychotic symptoms. These symptoms should improve within 6-8 weeks. Some individuals have rapid resolution of positive psychotic symptoms, whereas in others resolution of symptoms can take months. Negative symptoms may take longer to improve.
Consult a physician or psychiatrist if the client is still having positive psychotic symptoms after 6-8 weeks on a medication with good adherence, as the goal is to reduce their intensity and duration. Medications used in an acute phase may not be therapeutic once stabilized. Increase compliance by encouraging the client to be involved in decision-making about medications (for example, preferred route, duration of action).
For a considerable number of clients, long-term use of an antipsychotic is necessary to afford the chance of a stable partial or full remission. Yet, some schizophrenic clients may remain well for years, or even indefinitely, without medication. It is impossible to predict which clients may safely and permanently discontinue antipsychotic medication.
Depression in the stable phase indicates a trial of an antidepressant. Consult a physician.
Antipsychotic Side Effects
Inquire from the client and report all side effects to a physician. These include cognitive side effects (for example, sedation, cognitive dulling) and extrapyramidal side effects.
Common side effects include orthostatic hypotension, dry mouth, blurred vision, constipation, weight gain, drowsiness, increased risk for diabetes and high lipid counts, and sexual dysfunction. Some of the more important side effects to assess for include:
Neuroleptic malignant syndrome
Tachycardia, fever, labile blood pressure, muscle rigidity, increased creatinine and WBC, altered level of consciousness, and autonomic dysfunction is a medical emergency that can occur at any time with all antipsychotics. It occurs more often in males, younger clients, when there is rapid administration of antipsychotics, and in the presence of dehydration, exhaustion, and agitation. Antipsychotic medications should be stopped immediately and a physician consulted. Other supportive measures can be implemented, such as rehydration and cooling.
Clozapine has potentially fatal side effects (for example, agranulocytosis, myocarditis, seizures). Educate about their symptoms (for example, fever, chills, sore throat, chest pain, tachycardia).
Extrapyramidal Side Effects
Prevention is the key. If they appear, a physician may consider reducing dosages or even discontinuing the medication and starting another second-generation antipsychotic. They occur more often with first-generation antipsychotics, intermittent medication adherence/treatment, females, older adults, substance abusers, diabetes, and affective disorders. The side effects can occur with second-generation medications and be more subtle.
Upon initiating an antipsychotic treatment, monitor closely over the first days and weeks. Assess for:
Dystonia
Moderate to severe muscle spasms, usually of the neck (causing tilting of the head), back muscles (causing arching), and tongue or eye. These often dramatic and frightening effects are easily reversed.
Assess and stabilize ABC (airway, breathing, and circulation). Consult a physician about use of:
benztropine (Cogentin), 2 mg IM
Parkinsonian Side Effects
Muscle rigidity, tremor, facial masking, decreased concentration, cognitive slowing, drooling and loss of associated movements (akinesia/bradykinesia). Treatment involves reducing the medication dosage and/or administering oral antiparkinsonian agents such as benztropine, which may be prescribed by a physician.
Akathisia
Inner restlessness, which can be excruciatingly distressing and which only sometimes is manifested in outward restless movements. This side effect, which can only be alleviated in the same manner as the parkinsonian side effects, is sometimes mistaken for psychotic agitation. It can increase risk of suicide. If a dosage reduction does not work, a benzodiazepine or beta-blocker may be prescribed by a physician.
Months or years after antipsychotic treatment starts watch for:
Tardive Dyskinesia
A serious and often irreversible side effect. It is a neurologic condition characterized by the gradual appearance of repetitive involuntary movement. These movements usually involve facial musculature and appear as lip-smacking, chewing, sucking, and tongue-thrusting. At times, the extremities, limbs and trunk may be involved. A physician must be consulted if patients demonstrate symptoms of tardive dyskinesia.
Often treatment is a life-long proposition. Return to normal is unusual, and usually the person with schizophrenia remains disabled in one way or another and requires long-term rehabilitation and supportive care. Visits should be regular and frequent to prevent acute psychosis, to monitor drug compliance, effectiveness and side effects, to assess social support and efficacy of coping strategies, and to assess the phase of illness.Footnote 153 Visits also allow for more education, referrals to be made, and the client to ask questions. Regular follow-up is particularly important in first-episode psychosis as there tends to be poor medication adherence and increased rates of depression in the first 3 months.
Follow-up visits should occur weekly for the first 4-8 weeks of treatment (acute phase); then monthly for 6 months; then every 3 months (stabilization and stable phases) if they have had good functional recovery and stable living conditions (more often if client does not meet these characteristics, uses substance(s), has limited social support, is changing medication(s), and/or has stressful life events).
If on clozapine, the physician will order regular CBCs to monitor for agranulocytosis.
Throughout the illness, the following should be monitored at each visit. Intervene as needed:
Specific monitoring recommendations should be done at the initial visit and when required, in addition to the following times. Intervene as needed:
Medication side effect monitoring recommendations should be done before starting a new medication or dosage and when required.
If antipsychotics are withdrawn gradually, monitor regularly for signs and symptoms of a relapse for at least 2 years.
Acute Phase
For the first episode of psychosis, referral should be made urgently with a medevac to a hospital-based psychiatrist, or specialized early psychosis program.
Almost all acutely psychotic clients will need hospitalization and evacuation, and sometimes this must be accomplished on an involuntary basis.
The decision whether to treat the client on an outpatient basis or admit and/or evacuate the client to a hospital (voluntarily or involuntarily) depends on several factors. This decision must be made in consultation with a physician and/or psychiatrist. For further considerations, see "Hospitalization and Client Evacuation" and "Involuntary Admission."
Stable and Stabilization Phases
Refer the client to see a psychiatrist or physician if the client has not responded to treatment (for example, only partial recovery of symptoms or function), has not adhered to medication, has had intolerable medication side effects, has substance abuse problems, and/or has suicidal or homicidal ideation or actions.
Cognitive behavioural therapy is effective when paired with pharmacotherapy. It should be offered, if available. Cognitive behavioural therapy should be reserved for clients who have not improved with 2 different courses of an antipsychotic and/or those who are having symptoms of depression, anxiety and/or stress.
The client should be assisted to make use of educational, employment, training and recreational opportunities. Advice and assistance may also be required with respect to housing, financial assistance, legal matters and other social services. Refer clients to social and life skills training programs if offered in the community.
Facilitate referral or directly refer to mental health or social service team providers (for example, a psychiatrist, clinical nurse specialist, community mental health workers), as indicated. Long-term treatment should be done by or done under their supervision. The following are absolute indications for referral: acute psychosis, high suicide risk, attempted suicide, no evidence of social support, comorbid conditions, history of depression. If the client is treated on an outpatient basis, the therapist or others must be available to respond to a crisis at all times. Links with mental health resources in the community are to be made.
Information about self-injury is presented in the adolescent health section of the pediatric clinical guidelines.
Any unwanted touching or sexual actFootnote 158 that is forced on a victim by another person without consent. It includes kissing; touching; fondling; grabbing of the breast, buttocks or genitals; holding the victim and rubbing against or squeezing him/her; tearing or pulling at the victim's clothing; and attempted or completed vaginal, anal, or oral intercourse. It can occur due to the use of force or threat of force by the assailant (for example, physical violence or threats of physical violence to the victim or a loved one) or from a victim's inability to consent (for example, intoxication with alcohol or drugsFootnote 159). Victims are overpowered and controlled by their assailants against their will.
The assault may include the assailant using or threatening to use a weapon, or there may be more than one assailant during the same incident. Aggravated sexual assault occurs if the assailant wounds, beats, injures, or endangers the life of the victim.Footnote 160 All kinds of sexual assault are a crime, whether the offender is known or unknown to the victim. Spouses can be charged with sexual assault.
Sexual assault does not include exhibitionism, genital exposure, voyeurism, verbal or gestural obscenities, or sexual harassment, although these too may be unwanted and psychologically disturbing.
If a client is under 18 years of age the law is very specific as to what constitutes sexual abuse and/or sexual exploitation. For more information on these definitions and sexual assault indicators see "Sexual Abuse of Children" in the chapter, "Child Maltreatment."
Recovery after sexual assault has been identified as the sexual assault-trauma syndrome.
Recovery after sexual assault has been identified as the sexual assault-trauma syndrome.
Clients are often afraid to disclose sexual assault for a variety of reasons, but present to the clinic for medical attention directly or indirectly related to the incident (for example, pregnancy, injury, depression, self-harm). Be sensitive and supportive.
If any injury requires immediate attention, focus on that prior to completing the history and physical examination.
Document the history as described under "Family Violence" above. In addition, ask about:
Physical examinations for any form of sexual assault may require hours to complete. Ideally it is completed within 24 hours of the assault. Nurses may have to testify in court, if a case is heard.
As per regional policies, complete a forensic evidence (adult sexual assault examination) kit as soon as possible after the assault according to regional policies and with the permission of the client. Explain to the client that they do not have to report the sexual assault to the police, but that the evidence can be collected in case they decide to report it. Ensure all instructions for specimen collection are followed and completed with the materials provided in the kit (for example, fingernail scrapings, buccal mucosa swabs). Provide informed consent in writing prior to evidence being collected. Additionally, kits must be sealed, labeled and stored according to regional guidelines, ensuring that the chain of evidence is not broken at any time, even if the client is not planning on reporting the assault. Most kits do not test for sexually transmitted infections.
Have the client put on a gown to ensure that all body areas can be examined. Document the physical findings as required under "Family Violence" above. In addition, be sure to assess:
To receive informed consent, educate that test results will be part of their medical record. If their case of sexual assault goes to court, the results could be used as evidence for or against them (for example, laboratory-confirmed drug use).
Screen the alleged assailant whenever possible.
The more severe the offence (for example, rape compared to unwanted touching), the more likely the person's life will be negatively impacted.
Consult a physician when a client has an injury requiring consultation and/or if the client may require further medical or mental health care.
Immediately after the assault, allow the victim to wait in a quiet room away from any noise and confusion. Whenever possible, a same-gendered family member, resource person or advocate should remain with the client (if the client approves) throughout the stay at the medical facility (but they need to leave or be silent during the history and physical examination). When possible, ask the victim if he/she would prefer a female or male nurse. In all cases, another person should be present in the room during the medical examination.
Provide client education:
Discuss the client's need and wish for prophylaxis for sexually transmitted infection (STI) (see "Sexually Transmitted Infections" in the chapter, "Communicable Diseases").
Prophylaxis should be offered at the initial visit to clients if: the client may not return for follow-up, the assailant is known to have a specific sexually transmitted infection, it is requested by the client or parent, there are signs or symptoms of a sexually transmitted infection, the client declined sexually transmitted infection testing, and/or penetration (vaginal, oral, or anal) occurred. The following infections warrant consideration:
For a complete discussion of the clinical presentation and treatment of sexually transmitted infections, refer to and follow the
Canadian Guidelines on Sexually Transmitted Infections.
Determine whether the sexual assault could have resulted in a pregnancy; if so, discuss the possibility of administering oral emergency contraception immediately.
Offer antiemetics (for example, dimenhydrinate) if the client is prescribed both an emergency contraceptive and antibiotic(s).
If wounds were sustained and are dirty or occurred outside offer tetanus toxoid if the client's immunization status is unknown or if it has been > 5 years since their last immunization.
Follow-up in 1-2 weeks to:
Notifiable diseases may differ from one province or territory to another. Report any notifiable diseases in your province or territory according to local protocols.
Most clients will be able to be treated on an outpatient basis. If a medical evacuation may be warranted, consult a physician.
Refer the client to other appropriate and available services, depending on the client's wishes: sexual assault team/crisis centre, local police, mental health services, and/or victim support groups.
A counselling or psychotherapy referral should be considered early, if the client agrees. If it appears that the victim is unable to function, a psychiatric and psychological referral should be considered.
If anxiety or depression symptoms do not improve with psychotherapy or counselling, refer to a physician to consider prescribing antidepressants (selective serotonin reuptake inhibitors).
If the client is under 18 years of age, appropriate reporting of child abuse should take place. See "Sexual Abuse of Children" in chapter 5, "Child Maltreatment" of the Pediatric guidelines.
The Diagnostic and Statistical Manual IV criteria for substance abuse is the recurrent use of 1 or more substances with 1 or more of the following (related to substance use) for at least 1 year:Footnote 172
Substance dependence is one form of substance abuse, but most forms of substance abuse are not substance dependence.Footnote 173 Substances that have the potential for abuse or dependence are tobacco; inhalants; alcohol; steroids; and/or prescription, over-the-counter, and/or illegal drugs (for example, cannabis, cocaine, opiates, amphetamines, hallucinogens). Many individuals start by experimenting socially and/or using the substance casually.Footnote 174
Drug abuse is widespread in North American society. It affects all ages, races, and socioeconomic classes, although women are slightly less likely than men to use or abuse substances. Of Aboriginal people, 26.3% report a substance abuse concern.Footnote 175 The use of substances usually begins in adolescence. Youth aged 15-24 use drugs and experience harm due to their drug use at much higher rates than those over age 25.Footnote 176 Nicotine is the most commonly abused drug, followed by alcohol, marijuana and then stimulants such as amphetamines and cocaine. In First Nations and Inuit communities, gas and solvent sniffing also constitute a significant concern. Prescription (particularly oxycodone) and over-the-counter medications are increasingly being abused. Often clients abuse more than one substance. This increases the risk of negative consequences.
A resource that discusses substance abuse specific to the Aboriginal population is
Addictive Behaviours among Aboriginal People in Canada. It includes historical influences, cultural considerations for healing, successful treatment programs, and fact sheets on different addictions.
For specific information about substance abuse in children and adolescents, see "Substance Abuse" in the pediatric chapter 19, "Adolescent Health."
For specific information on cocaine poisoning, see Overdoses, Poisonings and Toxidromes in chapter 20 "General Emergencies and Major Trauma" of the Adult guidelines.
Many different factors may contribute to substance abuse, including genes, an individual's brain, childhood problems, mental health concerns, stress, and cultural factors. Environmental factors are suggested to influence drug initiation, whereas the development of substance abuse is related to genetics.
All clients can hide the fact that they use a substance unless they are directly asked about the issue. Pregnant women are more reluctant to reveal the use of a substance because of possible consequences. Discuss drug testing with new clients, pregnant women and clients presenting with new symptoms (eg, mental disorders, weight loss) or unexplained symptoms. Respect confidentiality at all times. Ask the client if he/she is open to discussing substance use and explain why detection tests may be needed. Get informed consent (at least verbally) and document the findings of the discussion in the client record.
Screening for substance use and abuse:
Substance Users
For alcohol and drug users:
One 'yes' suggests a possible alcohol or drug problem and warrants further investigation, whereas 2 or more 'yes' answers indicates serious alcohol or drug problems. However, CAGE-AID is not as predictive for women, youth, or the elderly. Therefore, for alcohol users, females drinking > 1 drink a day (or > 3 at one time or > 7 per week) or males drinking more than 2 drinks a day (or > 4 at one time or > 14 per week) are at a higher risk of alcohol-related problems.Footnote 184
| Class of Substance | Examples of Substances | Signs and Symptoms of Dependence |
|---|---|---|
Table 1 footnotes
|
||
| Cannabis CompoundsFootnote 187,Footnote 188 -- affect cognition, emotions and actions; contain THC |
|
|
| Depressants -- slow down central nervous system |
|
|
|
|
|
|
|
|
|
|
|
| StimulantsFootnote 190,Footnote 191,Footnote 192,Footnote 193,Footnote 194 -- speed up the central nervous system |
|
|
| HallucinogensFootnote 195,Footnote 196,Footnote 197 -- distort senses, emotions, feelings, and thoughts; may cause hallucinations at high doses |
|
|
Also assess the following in all clients who use substances:
Assess for:
Urine drug screen and serum alcohol levels can be completed to detect recent use, if medically necessary and if the client consents. Be aware that the client may substitute another substance for or dilute a urine sample.
If client has used injection drugs (even once) or is an intranasal cocaine user, test for HIV, hepatitis B and hepatitis C.
Substance use has many potential and real consequences. These include:
Of those who abuse drugs 53% also have a mental illness.Footnote 202 Complications related to a specific substance are described in the
Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): Manual for use in Primary Care on pages 11-18.
Treatment success for addictions depends on level of functioning at beginning of treatment, usual functioning, comorbid conditions, and client support systems. Comorbid conditions (for example, homeless, mental health concerns, relationship issues) must be addressed (for example, treated) during treatment, as they may be an underlying factor for substance abuse.
Base treatment on the client's individual goals. Goals early on should be easily attainable.
Stigma around addiction prevents families and individuals from seeking help and/or acknowledging the problem. One way to decrease stigma is by using language that puts the person first (for example, people with substance use problems).
All Clients (even if they do not use substances)
Stages of Change: A well known model of behaviour change that provides a framework for how people change and their readiness to change is often used to provide appropriate interventions for a client's current stage of change. For more information see pages 7-10 and 28-30 of the
ASSIST-linked Brief Intervention for Hazardous and Harmful Substance Use: Manual for Use in Primary Care Further information is available from the
Centre for Addictions and Mental Health.
Substance Users
See headings below for specific information and interventions for some substances of abuse. Brief interventions are useful. The following interventions apply to all users of substances of abuse:
Treatment for an addiction depends on the goal(s) of the client. Many are reluctant to agree to abstinence programs.Footnote 208 Options for treatment can include:
Clients and/or their families can get information, support, and/or find out about resources through the following services:
Occasionally, medications (for example naltrexone, disulfiram, methadone) are used to decrease the likelihood of relapse once abstinence has occurred. However, it is only helpful when combined with counselling and must be prescribed by a physician.
After completion of an addiction treatment program, regularly assess the client's recovery progress (for example, ask about cravings, using small amounts, anxiety, depression, relationships, and ability to function at school/work) in order to help prevent relapse. Discuss with a physician whether this should include urine drug testing.
Even if the client does not agree to an intervention or treatment, each time they visit monitor their use and encourage them to consider reducing or abstaining from use.
"Treatment is cost-effective, and even multiple episodes of treatment are worthwhile."Footnote 209 Clients who undergo treatment have less disability than those who do not. If the client has an addiction and agrees (the client has decided to change), in collaboration with a physician, refer to an appropriate (for the individual client, the substance, and the level of addiction) addictions treatment program or an addictions counselor. High-risk clients (as per
World Health Organization's ASSIST Tool risk levels) in particular should be referred to a physician, a treatment program, and/or a counselor for further assessment and treatment.Footnote 210 Counselling is a common component of all treatment programs and some have self-help groups. Some programs may involve families and/or employers. Consult a physician to assist in referrals to treatment programs.
The Diagnostic and Statistical Manual IV criteria for alcohol abuse is recurrent alcohol use with 1 or more of the following for at least 1 year:Footnote 214
See "Substance Abuse" above for the criteria for alcohol (substance) dependence.
Binge drinking is when a male consumes 5 or more drinks at one time or a female consumes 4 or more.
Risky drinking is when a woman has more than 7 drinks a week or 3 drinks at a time or when a male has more than 14 drinks a week or 4 drinks at a time.
More Aboriginals (34%) consume no alcohol when compared with the Canadian population as a whole (21%); however, the number of heavy drinkers (= 5 drinks/week) who are Aboriginal is double that of the Canadian population. Of those who abuse alcohol, 37% also have a mental illness.Footnote 215 Of First Nations young adults, 83% drank alcohol in the past year. Also, First Nations males are twice as likely to drink weekly when compared to females.Footnote 216 Lastly, 10.2% of Aboriginal females admit to binge drinking at least weekly (higher than the rate for other Canadian females).Footnote 217
Drinking alcohol during pregnancy causes more preventable birth defects than anything else in North America. There are 365 babies born in Canada every year with fetal alcohol syndromeFootnote 218 (approximately 1% of births)Footnote 219 and the incidence is very high in the Canadian Aboriginal community (one study found 16% of children in one British Columbia community).Footnote 220 This is likely related to determinants of health (for example, poverty).
Ethanol is found in standard alcoholic drinks as well as household products like mouthwash, perfume, cologne, baking extracts, and some over-the-counter medications.Footnote 221
The definition, clinical manifestations and treatment for acute alcohol withdrawal and alcohol withdrawal delirium are outlined in other sections of the adult mental health chapter.
For specific information about alcohol abuse in children and adolescents, see "Alcohol Abuse."
A combination of biological (including genetics), psychosocial and environmental factors.
Risk factors for alcohol use in pregnancy:Footnote 223
Screen all clients for alcohol use and abuse, as detailed above under "Substance Abuse" annually. Ensure the following groups are screened: females of child-bearing age and those who are pregnant,Footnote 224 clients with a family history of alcohol abuse, those who smoke, and clients who are frequently injured.
A single screening question for alcohol use or dependence may be as effective as longer questionnaires (for example, CAGE-AID,
Alcohol Use Disorder Identification Test,
CRAFFT for adolescents). An example is, "How many times in the past year have you had 5 (men) or 4 (women) or more drinks in a day?"Footnote 225
For clients whose screen is positive for alcohol use, in addition to those questions listed under "Substance Abuse" above, ask about:
Physical findings may be normal or there may be any of the following:
In an acutely intoxicated client rule out the following, which may co-exist with alcohol intoxication:
No tests should be used to screen clients for alcohol use. Blood alcohol and ethanol concentrations do not correspond with the physical symptoms of intoxication.
Liver function tests (AST, ALT, GGT), blood alcohol and ethanol concentration, upon physician consultation, as liver function tests correlate very poorly to alcohol use and abuse. A complete liver panel including albumin, PT/PTT and bilirubin should be evaluated for patients who have suspected cirrhosis or alcoholic hepatitis.
Acutely intoxicated patients should have a rapid capillary glucose measurement to rule out hypoglycemia.
Consult a physician before instituting medications, if the client is acutely intoxicated, and when assistance is needed to refer a client to a treatment program.
All Alcohol Abusing and/or Dependent Clients
Brief interventions and motivational interviewing as described under "Substance Abuse" have been very successful in treatment of alcohol abuse, but not alcohol dependence.
If a client is acutely agitated and/or is violent, medication can be administered (see "Violent or Acutely Agitated Psychiatric Clients").
Alcohol Dependent Clients
Clients with Acute Alcohol IntoxicationFootnote 231
Encourage clients who are alcohol abusers or dependent to take a daily multivitamin containing folic acid.
For clients who are alcohol dependent, who want to decrease their alcohol consumption, and prefer medication instead of nonpharmacologic interventions (and are not pregnant), the following are examples of medications that may be prescribed by a physician: naltrexone, acamprosate. These medications are often initiated while the client is undergoing treatment for intoxication or withdrawal, although naltrexone can be started while a client is still drinking. Six months of medication is common. If medication is prescribed, educate about medication side effects and their tendency to decrease with continued treatment.
Acute Alcohol Intoxication
thiamine 100 mg IV (only if client is in a coma)
Continue thiamine 100 mg PO or IV daily for up to 3 days or until seen by a physician.
Monitor for hypoglycemia to assess need for glucose administration.
Screen clients for alcohol use annually.
For clients who now abstain or who have recovered from alcohol abuse or dependence, follow up at least monthly for the first year (or 6 months after the end of pharmacologic treatment) to assess for relapse, treatment response and goals, medication side effects and adherence, and early signs of relapse. Continue to encourage Alcoholics Anonymous participation (if available), be supportive, and ensure comorbid anxiety and depression are treated throughout the follow-up period. Perform any laboratory testing required if the client is taking a medication (for example, naltrexone requires liver function tests).
A referral to a planned withdrawal program can be made if the alcohol dependent client is not already in withdrawal and the client agrees. Refer the client to a physician, social worker or National Native Alcohol and Drug Abuse Program (NNADAP) worker to help them through alcohol withdrawal.
Refer clients at medium or high risk of alcohol abuse or dependence before becoming pregnant or during pregnancy, if they agree, for treatment.Footnote 224
For clients with acute alcohol intoxication and a decreased level of consciousness, consult a physician about a medevac.
According to the Diagnostic and Statistical Manual IVFootnote 235 it is a syndrome experienced after cessation of or reduction in alcohol ingestion by a person who has been drinking for several days or longer with at least 2 of the following symptoms occurring within hours to days, causing distress or social, occupational or other problems with functioning.
Symptoms are:
The amount of information gathered initially will depend on the client's medical condition. If a full history is not taken at the beginning, try to gather more information after the client is more comfortable.
Establish that the client has been using alcohol; the CAGE-AID and the
Clinical Institute Withdrawal Assessment for Alcohol-revised (CIWA-Ar) scale can help determine the severity of withdrawal. The CIWA-Ar scale describes the severity of withdrawal, helps determine appropriate care, and can help monitor a client during detoxification. It should be completed with those clients thought to be in alcohol withdrawal who can talk and who have drank in the past 5 days. Mild withdrawal is a CIWA-Ar score of 10-15 and moderate and severe withdrawal is a CIWA-Ar score of > 15.
If client admits to alcohol use and is able, discuss the history questions listed under "Substance Abuse" above (for example, CAGE-AID) and ask about:
Symptoms usually begin within 4-12 hours after cessation or reduction in drinking (but can appear after a couple of days). If withdrawal continues, symptoms are often worse on the second day and get better by day 4 or 5. Anxiety, insomnia and autonomic hyperactivity may last (at lower levels) for up to 6 months. Symptom intensity increases with successive episodes of withdrawal.
Alcohol withdrawal can be categorized by stages: minor (stage 1) and major (stage 2). The symptoms of alcohol withdrawal may progress to stage 3 delirium tremens.
Complete a full physical examination (including psychiatric examination) to assess for signs of alcohol withdrawal and to rule out comorbid conditions.
Rule out any differential diagnoses, in particular if the client has a decreased level of consciousness.
Consult a physician to arrange a medevac and if possible, before giving medications.
Psychological Support for Clients
For Clients with Hallucinations, Delusions, Illusions
Refer also to nonpharmacologic interventions that can be used for all substance users and alcohol abusers above.
Mild Symptoms (CIWA-Ar = 15)
Sedation as needed:
diazepam 10 mg PO q1h until client shows clinical improvement in symptoms (according to CIWA scale) or becomes mildly sedated (calm, but alert)
or
lorazepam 2 mg SL q1h prn, up to 3 doses
and
thiamine, 100 mg IM/IV daily for 3 days (to prevent Wernicke's encephalopathy); give before glucose
and
on an ongoing basis, a multivitamin with thiamine and folate PO daily
Moderate to Severe Symptoms (CIWA-Ar > 15)
Sedation as needed:
diazepam 10 mg IV q20 minutes until client shows clinical improvement in symptoms (according to CIWA-Ar scale) or becomes mildly sedated (calm, but alert); do not use in clients with severe liver disease or in respiratory distress
and
thiamine 100 mg IM/IV daily for 3 days (to prevent Wernicke's encephalopathy); give before glucose
and
on an ongoing basis, a multivitamin with thiamine and folate PO daily
If the patient is experiencing seizures, hallucinations or delusions, consult a physician.
After acute detoxification, rehabilitation may include medications to help the client recover from alcohol dependence and decrease the likelihood of relapse. These must be prescribed by a physician.
Clients with mild symptoms (CIWA-Ar = 15) should be monitored every hour. Clients with moderate to severe symptoms (CIWA-Ar > 15) should be monitored every 15 minutes. Assess for:
Treat comorbid conditions, as required.
Follow up with clients at least monthly for the first year after discharge from a detoxification program and at least biannually thereafter. Assess for relapse, treatment response and goals, medication side effects and adherence, and early signs of relapse. Continue to encourage Alcoholics Anonymous participation (if available), be supportive, and ensure comorbid anxiety and depression are treated throughout the follow-up period.
Medevac. Detoxification for all stages of withdrawal should take place in a supervised setting to monitor medication use (if medication is used), maximize safety and observe for signs of withdrawal seizures or delirium tremens. Consult a physician to discuss the medevac and ongoing care.
For information about the definition, clinical presentation and the management of inhalant abuse, see Inhalant Abuse.
A herbal substance that can cause intoxication, abuse, and dependence. See "Substance Abuse" above for the criteria for marijuana (substance) abuse and dependence.
Marijuana is the illicit drug most commonly used. Abuse of or dependence on marijuana is associated with abuse of alcohol or other drugs, mood disorders, anxiety disorders, and schizophrenia. A client dependent on marijuana, compared to one who abuses, is at a higher risk level for these problems.
Up to 36% of clients with pain have tried herbal cannabis for symptom relief (for example, pain, anorexia). Canadians can apply for a license to possess cannabis under the Medical Marijuana Access Regulations. There are also cannabis-based drugs (for example, nabilone, dronabinol) that are available for nausea and anorexia, but they are not approved for use in pain control. They are not known to lead to abuse or misuse, as their onset of action is not rapid and they do not have the same reinforcing properties as smoked marijuana does.Footnote 240
Some teens and adults do not see marijuana as a significant drug of abuse, even though it has negative effects on memory and motivation and a withdrawal period of more than 6 weeks. In a study looking at "the past 30 days," 22.4% of high school students report having used it.Footnote 241 Of Ontario students in grades 7 to 12, 26% had used it in the past year.
One third of First Nations youth self-report using marijuana in the past year. Twenty-nine percent of First Nations males aged 18-39 report using it daily. The use of marijuana by First Nations individuals is almost double the usage rate of Canadians in general at 26.7%.Footnote 216 Of cannabis users, 9% develop dependence.Footnote 242
Screen all clients for marijuana use and abuse, as detailed above under "Substance Abuse" if they report use and/or use is suspected. In particular, youth should be screened. If the screen is positive, continue with the history for substance users above. In addition, ask about signs and symptoms of marijuana intoxication and/or withdrawal, depending on the client's history.
Intoxication: Physiological symptoms include tachycardia, injected conjunctiva, increased respiratory rate, hypertension, increased appetite, dry mouth; usually pleasant, but may have dysphoria, panic, paranoia, hallucinations, anxiety; changes in mood, attention, sociability, concentration, short-term memory, perception (including risk assessment), thought content; also impaired cognition, judgment, and coordination that lasts much longer than the client feels "high;" occurs within minutes if inhaled and within hours if ingested
Withdrawal: May be uncomfortable and distressing, but does not threaten life. Symptoms include fatigue, yawning, psychomotor retardation, anxiety, depression, anorexia, anger, strange dreams, sleep changes, irritability, physical tension. Symptoms start 1 to 2 days after last intake, peaks at day 2 to 6 and resolves within 1 to 2 weeks
Urine drug test (if a physician agrees); usually used to monitor treatment progress and relapse.
Refer to nonpharmacologic interventions that can be used for all substance users. In addition to those:
Using one or more forms of nicotine/tobacco product (cigarettes, pipes, cigars, hookah, cigarillos, chewing tobacco and snuff): all can cause psychological and physical dependence.Footnote 250 See "Substance Abuse" above for the criteria for nicotine (substance) dependence. It is a chronic disorder that often requires multiple interventions.
Nicotine is one of the most addictive (and lethal) drugs known. Cigarette smoke (including second hand) has about 4,000 chemicals and poisons and 50 of these cause cancer. Each cigarette shortens a life by about 10 minutes. Smoking is the number one preventable cause of death and disability in CanadaFootnote 245 and the leading preventable risk factor for cardiovascular disease.Footnote 251
Almost every smoker started before age 18. Many who learn to smoke cigarettes become addicted. The majority of clients who smoke report that they would like to quit and almost 60% of students who smoked tried to quit in the past year. However, only 5-7% of those who try to quit without help are still abstinent 1 year later. The same numbers are over 4 times higher if the client receives help from a health care provider.Footnote 252 This and the fact that few smokers seek help to quit underscores the need for nurses to be actively involved in screening for tobacco use, assessing readiness to change, and motivating clients to stop smoking.
Population smoking rates are 62% for First Nations and 72% for Inuit individuals. This is about 3 times the Canadian rate. Of these individuals, 60% began before they were 16 years old.Footnote 253 Almost half of First Nations individuals (46%) smoke daily, although more in the age 18-29 group (54%) smoke daily and fewer in the older adult (= 60 years) group smoke daily (24%). More females than males smoke. Many First Nations children (36.6%) were exposed to some maternal smoking.Footnote 254
For specific information about nicotine dependence in children and adolescents, see "Nicotine Dependence."
In addition to those risk factors for all substances:
All clients should be screened for nicotine use every time they present to the clinic (for example, have you used any tobacco product in the past 7 days? 6 months?). Ensure that you distinguish between use of traditional (for example, ceremonial) tobacco and commercial tobacco and respect the difference. Refer to the history of substance abuse that can be used to screen all clients. If the screen is positive, continue with the history for substance users above. In addition to those questions, ask about:
The following complications are for those who smoke. Some of them are also for those exposed to second-hand smoke.
If clients are using a tobacco product, a brief intervention (for example, 1-3 minutes) that recommends smoking cessation should be given, along with an offer of support and a helpline number, at a minimum. More intense interventions (for example, longer and at least 4 counselling sessions) for smoking cessation should also be used as they are more effective. The nurse should also consult and/or refer to another care provider for pharmacologic interventions and for more intense interventions if they do not have the knowledge to provide them. All interventions should be tailored to the First Nations and Inuit client and be culturally appropriate. Adolescents and pregnant, breastfeeding, and postpartum females in particular should have intense interventions to decrease the harm to others' and/or the client's health.
For clients interested in making a quit attempt, consult with and/or refer them to a physician, nurse practitioner or smoking cessation expert for counselling and/or pharmacologic treatment.
Refer to nonpharmacologic interventions that can be used for all substance users above. In addition:
Benefits of Smoking CessationFootnote 261,Footnote 255
Cessation by age 40 avoids most tobacco-related diseases, but after this time there are still many health benefits.
Consequences of Smoking Cessation (Withdrawal)Footnote 255
Consult with a physician or a nurse practitioner to prescribe a smoking cessation aid. Smoking cessation aids include nicotine substitution (for example, patch, gum) or non-nicotine drugs (for example, varenicline, bupropion). Note that these are covered by Non-Insured Health Benefits with an annual limit.Footnote 265
For pregnant and breastfeeding women intermittent nicotine substitution (for example, gum) is preferred over the nicotine patch.
A follow-up visit at least once before the quit date and within 3-7 days after quitting should be scheduled and/or done by telephone. Provide weekly follow-up for at least 3-6 months as needed for all those who have quit. Monitor for abstinence (if so, congratulate and compliment), relapse (if so, ask about willingness to quit again), and depression. Provide support, address concerns with concrete solutions, and continue/modify interventions as required.
Provide regular, scheduled follow-up for those who use tobacco products and are not interested in quitting. Educate clients at their stage of change for those not ready to quit.
For those who were successful quitting, follow up at least annually after the first year of cessation.
Refer clients wishing treatment to a community stop-smoking treatment program (if available) and/or a physician or nurse practitioner for both counselling and pharmacologic intervention.
Taking a prescription or nonprescription drug in a way that deviates from medical, legal, and/or social standards (for example, is not prescribed for the client, taking it in a route or at a dosage other than that prescribed, taking it for recreational purposes, not to improve an illness). The drug can cause intoxication, abuse and/or dependence. See "Substance Abuse" for the criteria for drug (substance) abuse and dependence.
Many types of medications can cause dependence and they are regulated by the federal Controlled Drugs and Substances Act. The most common classes are:Footnote 273
A number of First Nations communities have declared a state of emergency over the abuse of prescription narcotics, particularly oxycodone-containing drugs.Footnote 274
Nonprescription drugs (for example, caffeine, pseudophedrine, dextromethorphan, herbal remedies, diphenoxylate) may be abused, but there is little risk for dependence.
Almost half of Aboriginals using addiction treatment centres have a problem with prescription drugs: 74% abuse benzodiazepines and over 60% abuse more than one prescription drug.Footnote 253 Opioid abuse is the third most common substance of abuse after alcohol and marijuana. Older adults are at risk for physical dependence on sedative-hypnotics, antidepressants, and pain medications. Females are likely to misuse prescription medication more than males.Footnote 275
Information and tools for care providers, mainly related to opioid addiction and drug diversion, is available at
Paincare.ca. The site requires registration, but it is free.
Prescription drugs are popular because individuals think they are safer than street drugs and that it is legal to take them without a prescription. These reasons are in addition to the other reasons clients use substances (for example, to relax or feel good, to decrease appetite, to experiment, peer pressure, due to addiction).Footnote 276
Refer to the "History" and "Physical Findings" that can be used for all substance users above. In addition to those questions, ask (including friends and family, if possible), observe, and review the client's chart for:
The Clinical Institute Withdrawal Assessment from Benzodiazepines (CIWA-B) scale describes the severity of withdrawal, helps determine appropriate care, and can help monitor a client during detoxification. It may be used to assess clients thought to be in benzodiazepine withdrawal. Mild withdrawal is a CIWA-B score of = 20, and moderate and severe withdrawal is a
CIWA-B score of > 20. The CIWA-B is available on pages 5-21 to 5-23.
The
Clinical Opiate Withdrawal Scale (COWS) can be used to screen for withdrawal symptoms of clients thought to be on opioids.
Prior to prescribing a controlled substance (or consulting a physician about a prescription) understand the clinical, regulatory and legal responsibilities. The assessment includes:
| Medication | Signs and Symptoms | Most Severe Symptoms | Length of Recovery |
|---|---|---|---|
| BenzodiazepineFootnote 281 Potentially serious medical complications |
|
Days 3-7 (if shorter half life) Up to 3 weeks (if longer half life) |
2 -4 weeks; can have persistent symptoms up to 1 year |
| Opioids Uncomfortable, but no serious symptoms or medical complications |
|
Days 2-3 | 5-10 days, except methadone is much longer (cravings for many months) |
Urine and/or serum drug testing is an option for some prescription drugs being abused, but it is not usually used for diagnosis (except if there is an inadequate history). It may be helpful to monitor treatment. Consult a physician before completing the tests.
Do lab tests to rule out and/or assess comorbid conditions. If the client has shared needles in the past, screen for hepatitis A, B and C, and HIV.
The physician who prescribes the prescription drug should be consulted if abuse is suspected (for example, client history is positive for one or more potential indicators). They may wish to use a number of resources, including a client treatment agreement which is available for opioids, but can be adapted for other prescription drugs, under Pain Management Tools, Addiction Assessment at
Paincare.ca The site requires registration, but it is free.
Consult a physician about individuals known to be abusing or who are dependent on prescription drugs. They must also be consulted if an individual is requesting treatment, as some prescription drugs require other medications to help with withdrawal symptoms and/or require tapering of dosages. The physician can help determine an appropriate treatment program.
Refer to nonpharmacologic interventions that can be used for all substance users above. In addition:
Consult a physician about appropriate withdrawal protocols for prescription drug abusers requesting treatment and/or those experiencing withdrawal symptoms (for example, client should receive medication for nausea).
Benzodiazepine withdrawal treatment involves replacing usual dosage with long half-life benzodiazepine and then gradual tapering.
Opioid withdrawal treatment may include the use of methadone, naloxone or buprenorphine. If a client is prescribed methadone, more information and practice recommendations are available in
Supporting Clients on Methadone Maintenance Treatment, a Registered Nurses Association of Ontario Best Practice Guideline.
Frequent follow-up should be completed during withdrawal and treatment to support the client and to monitor for relapse.
Refer client to an addiction specialist and/or treatment program for the specific medication that the client is abusing. Refer all clients interested in treatment for cognitive behavioural therapy, if available.
Medevac clients who are undergoing withdrawal, after consultation with a physician.
Emergency EvaluationFootnote 285
Emergency psychiatric evaluations generally occur in response to thoughts, feelings, or urges to act that are intolerable to the patient, or to behavior that prompts urgent action by others, such as violent or self-injurious behavior, threats of harm to self or others, failure to care for oneself, bizarre or confused behavior, or intense expressions of distress. Patients presenting for emergency psychiatric evaluation have a high prevalence of combined general medical and psychiatric illness, recent trauma, substance use and substance-related conditions, and cognitive impairment. General medical and psychiatric evaluations should be coordinated. Patients who will be discharged to the community after an emergency evaluation or individuals with significant symptoms but without apparent acute risk to self or others, may require more extensive evaluation than those who will be transferred to provincial facilities or services.
Acute alcohol withdrawal with sudden and severe mental status and neurologic changes. Also known as "delirium tremens" or "the DTs." It is the third and most serious stage of alcohol withdrawal.
This condition should be regarded as a medical emergency. If a client has any of the signs or symptoms, they should be considered to have impending delirium tremens.
About 5% of clients experiencing alcohol withdrawal will have delirium tremens. Up to 5% of those with delirium tremens that is treated early and appropriately die, but if the condition is not treated the rate increases.
The cause involves the cumulative toxic effects of excessive alcohol intake and chronic nutritional deficiencies over an extended period of time. The most common precipitating factor is cessation or reduction in drinking, although the condition may also result from acute infection or head injury in a person who continues to drink.
Complete as much of the history as possible, as described under "Acute Alcohol Withdrawal."
Onset usually occurs the second to fourth day (48-96 hours) after cessation or reduction in drinking, although it occasionally occurs earlier (but not within hours of cessation). Client will have had one or more minor and major symptom(s) of withdrawal prior to the symptoms of delirium tremens.
Clinical features develop over a short period and fluctuate over the course of a day. Exacerbations often occur at night.
The condition usually runs its course in 1-5 days but may persist for several weeks depending on premorbid personality, physical condition, severity of complications, and promptness and thoroughness of treatment.
The following signs and symptoms are more specific to delirium tremens, but the client may also have one or more of the minor and major symptom(s) of withdrawal at the same time.
Most findings are not specific, but examine for signs and symptoms as described above and assess:
Complete the tests listed under "Acute Alcohol Withdrawal." In addition, do creatinine kinase, lipase, ketones, serum ethanol concentration, blood cultures, and EKG.
Place client on a cardiac monitor and pulse oximeter, so that they can be monitored.
Assess and stabilize ABCs (airway, breathing, and circulation). Treat presenting seizures as necessary.
Consult a physician as soon as possible. If the client is not responding to benzodiazepines and the physician agrees, consult your regional poison control centre.
Hydration and Nutrition
Encourage Orientation
Decrease Anxiety
Rest
Safety
Interventions for clients with hallucinations, delusions and illusions are described under "Nonpharmacologic Interventions" for acute alcohol withdrawal.
Sedatives (aim to achieve calm, alert, peaceful state):
diazepam (Valium), 10 mg IV, one dose
and
thiamine 100 mg IM/IV daily for 3 days (to prevent Wernicke's encephalopathy); give before glucose
and
consider a multivitamin with thiamine and folate PO daily on an ongoing basis
Clients may require large doses of diazepam to become sedated. Therefore, these are the initial dosages upon physician consultation. Treat those who do not respond to high-dose benzodiazepines (for example, > 50 mg diazepam within first hour or > 200 mg diazepam within first 4 hours) with other medications as directed by a physician.
For hallucinations and/or delusions, consult a physician.
Every 15 min until stable and then every hour assess:
Medevac as soon as possible. Hospitalization is necessary to ensure safety (for example, airway), supervision, full medical management and avoidance of further alcohol consumption.
The client should be referred to rehabilitation after acute detoxification is completed.
Acute (hours to days) deterioration of ability to maintain or shift attention or focus, consequently accompanied by disorientation, decreased awareness and fluctuating level of consciousness and often associated with perceptual disturbances or changes in cognition (for example impaired recent memory and disorganized thoughts, language disturbance) not related to dementia; may be psychomotor changes (hyper- or hypo-active) and/or emotional disturbances (for example, hallucinations) usually due to an underlying organic problem (for example, medical illness, substance intoxication, medication side effect).
Be suspicious of this diagnosis, as it is often missed. Commonly seen in but not limited to the elderly. It has a large list of differential diagnoses for underlying causes. More than one factor may be involved.
Elicit the history from the client, but it is just as important to elicit corroborating information from a caregiver, friend or the family (informant).
The physical exam is directed by the different potential causes, as generated by the history. A full physical exam should be completed and must include the following:
Unless the underlying cause is obvious, blood should be drawn for the following tests:
Other investigations will be driven by the history and presentation.
If unsure if the client is experiencing delirium, assume that they are and rule out common medical causes. Management is ultimately driven by the causative factor(s).
Delirium in older adults is a medical emergency. Consult a physician if client is assessed as delirious or in acute distress, if there are unexplained new neurologic symptoms or focal deficits, if there is acute onset cognitive impairment, if the client has rapidly progressing symptoms (neurologic or cognitive), or if there are risk factors for serious intracranial pathology (for example, anticoagulant medication, history of trauma, previous cancer).
If alcohol withdrawal is suspected, manage according to guidelines under "Alcohol Withdrawal" and "Alcohol Withdrawal Delirium."
If agitation or behavioural issues are of concern, manage according to guidelines in "Violent or Acutely Agitated Psychiatric Clients."
If at all possible, do not medicate. In particular, avoid sedation, as it may cause falls and worsen symptoms of impairment. Pharmacologic treatment is prescribed, in consultation with a physician, and aimed at the suspected underlying illness that caused the delirium.
While awaiting Medevac, regularly monitor symptom severity and response to any medications given.
If client goes home, follow up regularly (for example, weekly or more often as necessary), preferably on a home visit, to enable you to assess the client functioning in his or her own environment. Delirium may take weeks to months to resolve.
Medevac is necessary for clients with delirium, potential underlying organic pathology or if the risk-safety assessment requires that client be admitted to hospital. The decision as to whether to treat the client on an outpatient basis or admit and/or evacuate the client to a hospital (voluntarily or involuntarily) depends on several factors. This decision must be made in consultation with a physician. For further considerations, see "Hospitalization and Client Evacuation" and "Involuntary Admission."
Suicidal behaviour is an individual's actions that range from fleeting suicidal thoughts to completed suicide." Suicide is death that occurs as the result of an action by an individual who knows that the action will cause death.
Suicidal behaviour is an individual's actions that range from fleeting suicidal thoughts to completed suicide."Footnote 297 Suicide is death that occurs as the result of an action by an individual who knows that the action will cause death.Footnote 298
Suicide is the leading cause of death for Aboriginals under age 44.Footnote 300 In 2000, suicide accounted for 22% of all deaths among First Nations youth (10-19 years) and 16% among all young adults (20-44 years).Footnote 301 The suicide rates for First Nations youth (10-19 years) are 4.3 times greater than for the rest of Canada and for Inuit youth were approximately 11.6 times higher in the year 2000.Footnote 302 However, these rates may not be true in all Aboriginal communities: some have much higher rates (for example, eight hundred percent higher than the national average on some reserves) and others much lower rates, or have no suicides at all.Footnote 303 More females (18.5%) than males (13.1%) attempt suicide,Footnote 304 but males are four times more likely to be successful (for example, die) during a suicide attempt than females as they usually choose more immediately lethal methods. There are many more attempts than those who are actually successful, particularly in the adolescent age group.Footnote 305 Thirty-one percent of First Nations adults (21% of youth) state that they have seriously considered suicide in their lifetime and 15% (9.6% of youth) have attempted suicide. Ten percent of First Nations youth have thought about suicide at least once by age 12 and this rate increases to 30% by age 17.Footnote 306
Approximately 1 in 5 First Nations youth have had a close friend or family member commit suicide in the past year. Suicides in Aboriginal communities often occur in clusters. A suicide cluster refers to a group of suicides or suicide attempts, or both, that occur closer together in time and space than would normally be expected in a given community.Footnote 307
Predicting suicide is difficult, because it is relatively rare. Some risk factors can change from moment to moment, (for instance, substance use)Footnote 311 and no risk factor alone can accurately predict suicidality.Footnote 312 Key considerations include:
Risk factors can be categorized as being either dynamic and modifiable or static and unmodifiable. Modifiable risk factors are those that are amendable to change. This is an important consideration, as the identification of modifiable risk factors should be used to direct decision-making regarding intervention and support planning.Footnote 316
Establish a therapeutic relationship with the client, interview them alone and assure confidentiality. Open questions should be used when possible and the client allowed to talk freely, express emotion, and say what is wrong. However, closed questions will also need to be used to help ensure clear responses. Note verbal and non-verbal communication clues. Information should be obtained from both the client and significant others (for example, family, friends and/or professionals).
Asking clients about suicide will not give them the idea or encourage them to commit suicide. All clients disclosing thoughts related or potentially related to suicide should be taken seriously and then have a suicide risk assessment conducted.
Assess for those at high risk of attempting suicide (warranting a suicide risk assessment), using the mnemonic SADPERSONS + Family HistoryFootnote 318:
S - Sex (females > males, but more males complete suicide)
A - Age over 16
D - Depression (including insomnia, restlessness)
P - Previous attempts (including the methods)
E - Ethanol abuse (or other substances)
R - lost Rational thinking (for example, voices telling client to harm self, poor impulse control)
S - lack of Social support
O - Organized plan (lethality of method, preparation for attempt)
N - No significant other
S - Sickness (for example, acute or chronic condition, terminal illness) and/or Stressors
F - First-degree relative
Screening for suicidal ideation is warranted in those at high risk of attempting suicide due to the suffering these individuals may experience.
A suicide risk assessment includes an assessment of:
Physical findings include the mental status exam. Assess for:
Perform a physical exam to rule out an underlying medical condition.
Consider ordering the following tests, after consultation with a physician: serum toxicology screen, urine pregnancy test, serum drug or alcohol screening, TSH.
If a client is intoxicated it is very difficult to conduct an accurate risk assessment and provide interventions. Therefore, they should be kept in a safe environment (for example, jail) with sympathetic support and continuous monitoring until sober and then reassessed.
Reduce immediate risk, manage underlying concerns, improve self-esteem, increase sense of importance in the family and/or socially, and encourage healing.
Consult a physician if the client has: moderate or severe depression; depression and a comorbid mental illness; attempted suicide previously or just prior to the assessment; been self-mutilating; access to lethal means; hallucinations or delusions; and/or serious and imminent (active plan and access to means) intent to commit suicide. Also consult if there is lack of family or friends to care for the client and/or there is increased family or nurse anxiety due to the client's behaviour.
If the client will not agree to the involvement of a concerned third party adult in the safety plan and the client has a plan (even if they state that they will not carry it out), a physician should be consulted.Footnote 323
Threatened or Suspected Suicidal Ideation
Determine the client's level of risk of completing their plan, based on the information gathered. Ensure the physical safety of the nurse and client prior to intervening (for example, remove objects that could be used to commit suicide). Recognize the limits of your own personal responsibility and the impossibility of guaranteeing that an individual will not commit suicide even after intervention and treatment.
Work with clients to decrease the stigma surrounding attempted suicide and mental illness. Instill hope for the client and family that there is help available. Do not try to talk the person out of suicide or convince him or her that things are really not so bad. These efforts may only firm the person's resolve. Attending exclusively or primarily to the suicidal behaviour itself (threats, gestures or attempts) may reinforce or encourage suicidal behaviour. The role of front-line medical staff depends upon their training and the local presence or absence of specialists in health and social services.
Attempted Suicide
Provide medical treatment as required and consider the potential for a drug overdose in addition to the other method(s) used. Observe the client at the level appropriate for their current risk of further attempts.
Enact a safety plan and crisis intervention counselling as described above under "Threatened or Suspected Suicidal Ideation." In particular, ensure that potential means of suicide have been removed. Provide counselling for the individual, family, and possibly community. State that this experience may be positive and/or constructive, if the individual and family agree to make it so.
Survivors of a Completed SuicideFootnote 330
"For every suicide there may be many more people suffering from depression, anxiety, and other feelings of entrapment, powerlessness, and despair…. The circle of loss, grief, and mourning after suicide spreads outward in the community. In small Aboriginal communities where many people are related, and where many people face similar histories of personal and collective adversity, the impact of suicide may be especially widespread and severe."Footnote 331
Assess and provide interventions for those who were bereaved (for example, family, loved ones, peers, co-workers), within 2-3 days of the suicide, as they can experience grief with anger, despair, depression, feelings of blame, shame, an inability to comprehend what happened, and thoughts of suicide themselves. This can also be related to the stigma of suicide. Convey the understanding that their feelings are normal and that suicide was how the person chose to die. Be empathetic, console, and understand that they need to hear about the person who died. Encourage them and provide opportunity to talk about their grief and allow time to deal with their loss. Educate them that anniversaries of that person will be difficult, but that there may be an opportunity to start new traditions on these dates. Avoid sensationalizing, glorifying or vilifying their death. Specific interventions are described on page 105 of the Registered Nurses Association of Ontario's
Best practice guideline: Assessment and Care of Adults at Risk for Suicidal Ideation and Behaviour.
Resources that can be given to survivors include:
Various medications may be prescribed by a physician to help the client with their mood, sleep and/or anxiety. Educate about the medication and potential side effects.
Follow-up after suicidal ideation and/or suicidal attempts is very important. It should first occur within 48 hours and at least weekly until the client is stable. Some clients are relieved that someone is willing to talk about suicide, whereas others use these thoughts and/or behaviours to ask for help, as they are trying to communicate despair, frustration and/or unhappiness. The client who wants to end their life needs to be differentiated from the one who is asking for help, as there will be some difference in the interventions.
Regular follow-up visits or phone calls assess whether the client is using effective coping strategies (has implemented the plan), has social support from a third party (or needs additional support), and is finding resolution of the acute crisis phase (for example, no suicide attempts).Footnote 333,Footnote 334 They also allow for more education, referrals to be made, and the client to ask questions.
The safety agreement can be renewed as needed. Follow-up visits should include monitoring for depression and substance use.
Some clients can be managed on an outpatient basis with pharmacotherapy, psychotherapy and/or counselling support. All clients should be referred to a physician or psychiatrist, regardless of severity.
The decision whether to treat the client on an outpatient basis or admit and/or evacuate the client to a hospital (voluntarily or involuntarily) depends on several factors. This decision must be made in consultation with a physician and/or psychiatrist. For further considerations, see "Hospitalization and Client Evacuation" and "Involuntary Admission."
Facilitate referral or directly refer to mental health or social service team providers (for example, a psychiatrist, clinical nurse specialist, community mental health workers), as indicated, as long-term treatment should be done by or done under their supervision. The following are absolute indications for referral: high suicide risk, attempted suicide, no evidence of social support, comorbid conditions, history of depression. If the client is treated on an outpatient basis, the therapist or others must be available to respond at all times. Links with mental health resources in the community are to be made if the client agrees (for example, Native Aboriginal Youth Suicide Prevention Strategy worker).
A variety of strategies are needed to promote mental health. These may include:
Situations where the client or others have a high probability of being disabled and/or having their life at risk. They need first aid or require an immediate intervention. Acute agitation is anxiety with motor restlessness.
The majority of mental health clients are not particularly dangerous or violent. But, when clients behave violently or aggressively, the behaviour is often unpredictable and irrational, since it is a product of the client's psychopathology. The true source of the behaviour may not be apparent and actions may be illogical, as in the case of persecutory delusions, or actions may be abrupt and unexpected, as in hallucinatory states.
Violence in mentally ill clients occurs due to the same factors as in those without mental illness:
Try to predict and prepare for disturbed behaviour by noting the following:
Trigger factors and early warning signs are different for each client.
Violent or agitated clients should not wait for care as it can escalate aggression, but "preferential treatment" may defuse it. Additionally, these clients should not be in contact with others who might escalate their behaviours or provoke them
There are many potential underlying disorders that can cause a client to act violently. Not all people presenting with a violent behavior or even just a violent ideation, have a mental disorder. Violence can be grossly divided into cognitive and emotional: the former is usually more related to a criminal attitude than to mental disorders, the opposite is for the latterFootnote 345. A first objective is to distinguish between the two situations, although the distinction is not always clear. Furthermore, identifying whether the clinical situation is due to a substance related disorder or to a general medical condition related disorder will be valuable.
Substance Related Disorders (for example, withdrawal delirium)
General Medical Conditions Related Disorders (for example, delirium, dementia and neurological syndromes [such as complex partial seizures and brain temporal, frontal or limbic lesions]).
Serum alcohol and drug levels and others as directed by a physician or nurse practitioner.
These guidelines for the management of violence assume that the violent person is a bona fide psychiatric or medical client. In some cases, the individual may have a personality disorder for which emergency treatment is not possible or appropriate. In this situation, the violence is best viewed as a matter for the police.
Ultimately, you must use your own judgment to determine if and when to intervene with a potentially violent client. Trust your feelings and judgment. If you feel threatened, act accordingly.
In order of priority:
Whenever possible, medical consultation and assistance should be sought in dealing with violent clients. When circumstances make this impossible at the critical moment, the physician should be consulted as soon as possible afterward to discuss the action taken, the choice and dosage of any medication given, and the future plan of care. The correct diagnosis, if possible to determine the underlying cause, is very important in the case of the violent client, and a consultation is an essential part of the management procedure.
If you are concerned, try not to see the client alone. Interview the client in a private room, but ensure it is not isolated from other staff. Potential weapons (for example, electrical cords, scalpels) should not be present in the room being used and any potential weapons (for example, pens, belts) noted by the care provider. Additionally, have a way of alerting others of danger and the need for security personnel. Keep the door open and ensure that both you and the client have an unobstructed path to the door, so that either of you can escape from the room if the situation is perceived as dangerous. The care provider should be situated between the client and the door.
Do not see the client if he or she has a weapon of any sort. Call for assistance.
Use non-verbal and verbal methods to control and allow the client to calm down as much as possible before physical and/or chemical restraint is used. However, if the client is uncooperative, agitated, and/or violent and has early warning signs of violence they should be immediately restrained.
Verbal and Non-Verbal Techniques
Use the following techniques to build trust. However, observe and judge the effects of these actions, since what may be psychologically subduing or calming to one client may be provocative to another. Attempts to "talk a client down" may even increase some clients' agitation.
Physical assault may occur, even if precautions are taken. Summon help, take a sideward position with arms and legs ready to protect or deflect an assault. Keep the chin tucked to protect the neck. If threatened with a weapon or taken hostage do not reach for the weapon, make sudden movement, argue, bargain or make promises.
Knowledge of the three core components of crisis intervention theory (a precipitating event, perception of the event, and the client's usual coping methods) is fundamental to identifying and intervening with clients in crisis.Footnote 346 Crisis intervention services aim to build a therapeutic relationship including listening, acknowledging the client and family's experiences, taking the concern seriously, being supportive, decreasing anxiety, instilling hope, and using calm, clear, and simple communication. Crisis intervention also aims to increase the client's level of functioning.Footnote 347
If non-verbal and verbal prompts have been used and the client has not de-escalated, excuse yourself and leave the room to get help. Do not hesitate to call the police if the client becomes too threatening.
Physical Restraints
Involuntary restraint and involuntary hospitalization are addressed in laws and regulations of provinces and territories (such as provincial Mental Health Acts and the Criminal Code) and can be complemented by regional protocols. The respective legislations should be referred to and their implications clearly understood. To restrain someone or to force them to involuntarily undergo treatment in ways other than provided for by legislation can lead to civil litigation and criminal assault charges. If additional support from family, community members or law enforcement officers is not sufficient to assess a client, a colleague assessment and concurrent treatment plan is required before using restraints, as it is not a standard intervention. A client who has the capacity to make reasonable decisions and is not suicidal or homicidal should not be restrained without their consent.
If medication is contraindicated, inappropriate or insufficient, and physical restraints are deemed necessary to allow for a diagnostic examination, to administer medication, and/or to prevent injury:
If it is deemed in the client's best interest because he or she is at risk of injuring self, others or property, or is likely to leave the premises before adequate treatment and he/she did not respond to non-verbal and verbal de-escalation techniques, chemical sedation should be considered, either with or without physical restraints. If possible, consult a physician first. Otherwise, give:
lorazepam (Ativan), 1-2 mg PO or SL
OR
lorazepam (Ativan), 1-2 mg IM (NOTE: Always reserve injectable route as the last resort if a patient is non-compliant to oral route)
For agitated clients with a known schizophrenia, antipsychotic agents (for example, haloperidol) can be used instead or with lorazepam.
All clients should be offered and encouraged to take an oral medication, as the client may view an injection as a punishment. Use lower doses of medication in older adults.
Do not use benzodiazepines such as lorazepam in a person acutely intoxicated with alcohol without consulting a physician, as these drugs are additive for respiratory depression.
If the medication given does not work, consult a physician before administering anything else.
After Physical or Chemical Restraints are Applied/Given:
Evaluation after Client is De-escalated or Restrained
Clients > 40 years old with new psychiatric symptoms or with an acute onset of symptoms are more likely to have an organic cause (for example, delirium, stroke). If client is sedated and deteriorates, consider an infection or drug overdose.
Other Aspects of Monitoring
Evaluate the client's self-control and capacity for appropriate behaviour on a continuing basis. Watch for flare-ups of violent behaviour. Encourage the client to use their usual coping methods. Negotiate a realistic and concrete action plan, if the client is competent and capable.
If the client is under the influence of a substance, assess them frequently and keep them under observation until the client is no longer under the influence and a therapeutic intervention can be made.
If a secure room is used for confining a violent person after removal of restraints:
After the incident, debrief with all staff who were involved by discussing what happened, trigger factors, individual roles in the incident, current feelings and what can be done to address any concerns.
The decision whether to treat the client on an outpatient basis or admit and/or evacuate the client to a hospital (voluntarily or involuntarily) depends on several factors. This decision must be made in consultation with a physician and/or psychiatrist. For further considerations, see "Hospitalization and Client Evacuation" and "Involuntary Admission."
Consider creating a crisis protocol in advance of a situation:
Internet addresses are valid as of October 2011
Anxiety Disorder Association of Canada. Welcome to ADAC/ACTA; 2007.
Anxiety Treatment and Research Centre.
Information about anxiety disorders
BC Partners for Mental Health and Addiction.
Here to help: Understand more
Canadian Mental Health Association.
Understanding mental illness
Canadian Network for Mood and Anxiety Treatment.
Disorder information
Centre for Addiction and Mental Health. 1-800-463-6273 or www.camh.net
Centre for Addiction and Mental Health.
Resources for your patients and their families; 2009. (includes Mental Health and Addiction 101 online tutorials, and information on mental illnesses and substance use; some are written for youth)
Government of Canada.
Youth drug prevention for parents; 2010.
Health Canada. First Nations Inuit Health: Help on quitting smoking; 2008.
Humeniuk RE, Henry-Edwards S, Ali RL, Meena S.
Self-help strategies for cutting down or stopping substance use: a guide. Geneva: World Health Organization; 2010.
Mood Disorders Society of Canada.
What is bipolar disorder?; 2009.
Mood Disorders Society of Canada.
What is depression?; 2011.
National Aboriginal Health Organization.
Inuit tobacco free network; 2009.
Ontario Drug and Alcohol Registry of Treatment (for Ontario resources) at 1-800-565-8603 or www.dart.on.ca
Bickley, LS. Bates' guide to physical examination and history taking. 10th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2009.
Dains JE, Baumann LC, Scheibel, P. Advanced health assessment and clinical diagnosis in primary care. 3rd ed. Philadelphia, PA: Mosby Elsevier; 2007.
Filate W, Leung R, Ng D, Sinyor M. Essentials of clinical examination handbook. 5th ed. Toronto, ON: Medical Society, Faculty of Medicine, University of Toronto; 2005.
Gray J (Editor). Therapeutic choices. 5th ed. Ottawa, ON: Canadian Pharmacists Association; 2007.
Jensen B, Regier L (Editors). RxFiles: Drug comparison charts. 8th ed. Saskatoon, SK: Saskatoon Health Region; 2010, October.
Kasper DL, Braunwald E, Fauci A, et al. Harrison's principles of internal medicine. 16th ed. McGraw-Hill, 2005.
Lexchin J (Editor). Drug therapy for emergency physicans. Canadian Association of Emergency Physicians; 2002.
Prateek L, Waddel A. Toronto Notes -- MCCQE 2003 review notes.19th ed. Toronto, ON: University of Toronto Faculty of Medicine; 2003.
Rollnick S, Mason P, Butler C. Health behaviour change: A guide for practitioners. Toronto, ON: Churchill Livingstone; 1999. (An excellent book on motivational interviewing and brief interventions.)
Ryan-Wenger NA (Editor). Core curriculum for primary care pediatric nurse practitioners. St. Louis, MO: Mosby Elsevier; 2007.
Uphold C, Graham MV. Clinical guidelines in family practice. 4th ed. Gainsville, FL: Barmarrae Books Inc.; 2003.
Addiction issues:
Addiction risk screening
Ashton CH.
Benzodiazepines: How they work and how to withdraw. Newcastle upon Tyne, England: Royal Victoria Infirmary; 2011.
Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG.
AUDIT: Alcohol use disorders identification test: Guidelines for use in primary care. 2nd ed. Geneva: World Health Organization; 2001.
CAN-ADAPTT's Clinical Practice Guideline Development Group, Brosky G.
CAN-ADAPTT Canadian smoking cessation guideline: Counselling and psychosocial approaches. Toronto, ON: Centre for Addiction and Mental Health; 2011, February 2.
CAN-ADAPTT's Clinical Practice Guideline Development Group, Cote-Meek S.
CAN ADAPTT Canadian smoking cessation guideline: Specific populations: Aboriginal peoples. Toronto, ON: Centre for Addiction and Mental Health; 2010, November 22.
CAN-ADAPTT's Clinical Practice Guideline Development Group, O'Loughlin J.
CAN ADAPTT Canadian smoking cessation guideline: Specific populations: Youth (children and adolescents). Toronto, ON: Centre for Addiction and Mental Health; 2010, November 30.
CAN-ADAPTT's Clinical Practice Guideline Development Group, Ordean A.
CAN ADAPTT Canadian smoking cessation guideline: Specific populations: Pregnant and breastfeeding women. Toronto, ON: Centre for Addiction and Mental Health; 2010, November 24.
Canadian Mental Health Association.
Grief after suicide; 2010.
Canadian Mental Health Association.
Training enhancement in applied cessation counseling and health.
Canadian Mental Health Association.
Understanding Mental Illness; 2010.
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. Journal of Affective Disorders 2009;117:S1-S64.
Canadian Paediatric Society.
Fetal alcohol syndrome. Paediatric & Child Health 2002;7(3):161-74.
Canadian Paediatric Society, First Nations and Inuit Health Committee.
Use and misuse of tobacco among Aboriginal peoples. Paediatric and Child Health 2006;11(10):681-85. Reference No. FNIH06-01. Revised April 2010. Available: http://www.cps.ca/english/statements/II/FNIH06-01.htm
Canadian Psychiatric Association, Canadian Network for Mood and Anxiety Treatments. Clinical guidelines for the treatment of depressive disorders. Canadian Journal of Psychiatry 2001;46(Supplement1).
Canadian Psychiatric Association.
Clinical practice guidelines for schizophrenia. Canadian Journal of Psychiatry 2005; 50(13 supplement 1): 1S-56S.
Canadian Psychiatric Association & Schizophrenia Society of Canada.
Schizophrenia: The journey to recovery. A consumer and family guide to assessment and treatment; 2008.
Carson G, Cos LV, Crane J, Croteau P, et al.
Alcohol use and pregnancy consensus clinical guidelines. Journal of Obstetrics and Gynaecology Canada 2010;32(8 Supplement 3): S1-S32.
Centre for Addiction and Mental health.
Problem gambling: A guide for helping professionals; 2008.
Centre for Addiction and Mental Health.
Resources for your patients and their families; 2009.
Centre for Addiction and Mental Health, St. Joseph's Health Centre. (2010).
Primary Care; Addiction toolkit.
Champlain CVD Prevention Network. (2010).
Ottawa model for smoking cessation.
Chansonneuve D.
Addictive behaviours among Aboriginal people in Canada. Ottawa, ON: Aboriginal Health Foundation; 2007.
Cherniak D, Grant L, Mason R, et al.
SOGC clinical practice guidelines: Intimate partner violence consensus statement. JOGC 2005;157:365-88.
Chertkow H, Massoud F, Nasreddine Z, et al.
Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia. Canadian Medical Association Journal 2008: 178(10);1273-85.
Clark AJ, Lynch ME, Ware M, et al.
Guidelines for the use of cannabinoid compounds in chronic pain/. Pain Research & Management 2005;10(Supplement A):44A-46A.
Etherington J. Emergency management of acute alcohol problems, part 1. Canadian Family Physician 1996;42:2186-90.
Etherington J. Emergency management of acute alcohol problems, part 2. Canadian Family Physician 1996;42:2423-31.
Feldman HH, Jacova C, Robillard A, et al.
Diagnosis and treatment of dementia: 2. Diagnosis. Canadian Medical Association Journal 2008:178(7);825-36.
Folstein MF, Folstein SE, McHugh PR.
Folstein mini-mental state examination.
Four Worlds Centre for Development Learning, Bopp M, Bopp J, Lane P.
Aboriginal domestic violence in Canada. Ottawa, ON: Aboriginal Healing Foundation; 2003.
Gliatto MF, Rai AK.
Evaluation and treatment of clients with suicidal ideation. American Family Physician 1999, March 15.
Health Canada. Help on quitting smoking. Ottawa, ON: Author; 2008.
Hogan DB, Bailey P, Black S, et al.
Diagnosis and treatment of dementia: 4. Approach to management of mild to moderate dementia. Canadian Medical Association Journal 2008: 179(8); 787-793.
Hogan DB, Bailey P, Black S, et al.
Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia. Canadian Medical Association Journal 2008: 179(10); 1019-1026.
Holbrook AM, Crowther R, Lotter A, et al. Meta-analysis of benzodiazepine use in the treatment of acute alcohol withdrawal. CMAJ 1999;160(5):649-55.
Humeniuk RE, Henry-Edwards S, Ali RL, Poznyak V, Monteiro M.
The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): manual for use in primary care. Geneva: World Health Organization; 2010.
Humeniuk RE, Henry-Edwards S, Ali RL, Poznyak V, Monteiro M.
The ASSIST-linked brief intervention for hazardous and harmful substance use: manual for use in primary care. Geneva: World Health Organization; 2010.
Institute for Clinical and Evaluative Science.
The bipolar express. Informed 2006;12(3):1-3.
Kirmayer LJ, Brass GM, Holton T, et al.
Suicide among aboriginal people in Canada. Ottawa, ON: Aboriginal Healing Foundation; 2007.
Lam RW, Kennedy SH, Grigoriadis S, et al.
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults: III. Pharmacotherapy. Journal of Affective Disorders 2009;117:S26-S43.
Mayo Clinic Staff. (2009).
Drug addiction: Symptoms.
Mayo Clinic Staff. (2010).
Prescription drug abuse.
Mental Health Commission of Canada.
Out of the shadows at last.
McNaughton JL.
Brief interventions for depression in primary care: A systematic review. Canadian Family Physician 2009;55:789-96.
Mood Disorders Society of Canada.
Quick facts on mental illness and addictions in Canada. 2nd ed.; 2007:1-36.
Moses S. (2010).
Alcohol abuse DSM-IV criteria.
National Institute for Health and Clinical Excellence.
Schizophrenia: Core interventions in the treatment and management of schizophrenia in adults in primary and secondary care. NICE clinical guideline 82. London, England: Author; 2009.
National Institute on Drug Abuse. (n.d.).
Prescription medications.
National Institute on Drug Abuse. (n.d.).
Preventing and recognizing prescription drug abuse.
National Institute on Drug Abuse. (2010, September).
Research report series: Marijuana abuse.
National Institute of Health Pain Consortium. (2007).
Pain intensity scales.
Nova Scotia Early Psychosis Program. (2004).
The sooner the better: Education package.
Ontario Problem Gambling Research Centre. (2010).
Problem gambling framework.
Paincare.ca. (n.d.).
Pain management tools. Addiction Assessment section (the site requires a free registration)
Parikh SV, Segal ZV, Grigoriadis S, et al.
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults: II. Psychotherapy alone or in combination with antidepressant medication. Journal of Affective Disorders 2009; 117:S15-S25.
Patten SB, Kennedy SH, Lam RW, et al.
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults: 1. Classification, burden and principles of managment. Journal of Affective Disorders 2009;117:S5-S14.
Piver A, Yatham LN, Raymond W, Lam RW.
Bipolar spectrum disorders: New perspectives. Canadian Family Physician 2002;48(5) 896-904.
Public Health Agency of Canada.
Schizophrenia: A handbook for families. Ottawa, ON: Author; 2002.
Ravindran AV, Lam RW, Filteau MJ, et al.
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults: V. Complementary and alternative medicine treatments. Journal of Affective Disorders 2009;117:S54-S64.
Reading J. (2009, March).
A life course approach to the social determinants of health for Aboriginal peoples.
Registered Nurses Association of Ontario. (2009).
Best practice guideline: Assessment and care of adults at risk for suicidal ideation and behaviour.
Registered Nurses Association of Ontario. (Revised 2010).
Caregiving strategies for older adults with delirium, dementia and depression.
Registered Nurses Association of Ontario. (2007, March).
Integrating smoking cessation into daily nursing practice.
Registered Nurses Association of Ontario.
Nursing best practice guideline: Crisis intervention. Toronto, ON: Author.
Registered Nurses Association of Ontario. (2005).
Nursing best practice guideline: Interventions for postpartum depression.
Registered Nurses Association of Ontario. (Revised 2010).
Screening for delirium, dementia and depression in older adults.
Registered Nurses Association of Ontario. (2009). Supporting clients on methadone maintenance treatment.
Registered Nurses Association of Ontario. (2011).
Tobacco Free RNAO.
Registered Nurses Association of Ontario. (2005). Woman abuse: Screening, identification and initial response.
Saunders JB, Yang J.
Clinical protocols for detoxification in hospitals and detoxification facilities. Australia: Queensland Health; 2002
Smylie J.
SOGC policy statement: A guide for health professionals working with Aboriginal peoples: Health issues affecting Aboriginal peoples. Journal of the Society of Obstetricians and Gynaecologists of Canada 2001;23(1):54-68.
Society of Obstetricians and Gynecologists of Canada. (2009).
Sexuality and U.
Swinson RP, Antony MM, Bleau P, Chokka P, et al.
Clinical practice guidelines: Management of anxiety disorders. Canadian Journal of Psychiatry 2006;51(8) supplement 2:3S-92S.
Yatham LN, Kennedy SH, O'Donovan C, et al.
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disorders 2005;7(supplement 3):5-69.
Yatham LN, Kennedy SH, Schaffer A, et al.
Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disorders 2009;11:225-255.
World Health Organization. (2010, September).
Mental health: Strengthening our response, fact sheet 220.
Mood Disorders Society of Canada. (2009).
Quick facts: Mental illness & addiction in Canada. 3rd ed.
U.S. Department of Health and Human Services.
Mental Health: A Report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services; 1999. Chapter 4: Adults and mental health
Highlights from the report of the Royal Commission on Aboriginal Peoples. Ottawa, ON: Minister of Supply and Services Canada; 1996. The Urgent Need for Whole Health section
Romanow RJ. (2002, November).
Building on values: The future of health care in Canada. Ottawa, ON: Commission on the Future of Health Care in Canada. p. 218-19
Kirmayer LJ, Brass GM, Tait CL.
The mental health of Aboriginal peoples: Transformations of identity and community. Culture & Mental Health Research Unit 2001;10:5-25. p. 9-12
Mood Disorders Society of Canada. (2009).
Quick facts: Mental illness & addiction in Canada. 3rd ed. p. 4
Mental Health Working Group.
Mental wellness framework: A discussion document for comprehensive culturally appropriate mental health services in First Nations and Inuit communities. Ottawa, ON: Health Canada; 2002.
Hosman C, Jane-Llopis E, Saxena S (Editors).
Prevention of mental disorders: effective interventions and policy options summary report. Geneva, Switzerland: World Health Organization. p. 20-21, 23
Koplan C, Charuvastra A, Compton, MT, et al.
Prevention psychiatry. Psychiatric Annals 2007;37(5): 319-28. p. 323-24
Kirmayer L, Simpson C, Cargo M,
Healing traditions: culture, community and mental health promotion with Canadian Aboriginal peoples. Australasian Psychiatry 2003;11(Suppl): S15-23 p. S21
Cheung A, Saul D. The psychiatric exam. In: Filate W, Leung R, Ng D, Sinyor M. Essentials of clinical examination handbook. 5th ed. Toronto, ON: Medical Society, Faculty of Medicine, University of Toronto; 2005. p. 265-78.
Dains JE, Baumann LC, Scheibel, P. Advanced health assessment and clinical diagnosis in primary care. 3rd ed. Philadelphia, PA: Mosby Elsevier; 2007. p. 450-67
Dains JE, Baumann LC, Scheibel, P. Advanced health assessment and clinical diagnosis in primary care. 3rd ed. Philadelphia, PA: Mosby Elsevier; 2007. p. 453
Kneisl, CR, Wilson HK, Trigoboff E. (2004). Contemporary psychiatric - mental health nursing. Pearson Prentice Hall. Chapter 14. p. 304-33.
Swinson RP, Antony MM, Bleau P, Chokka P, et al.
Clinical practice guidelines: Management of anxiety disorders. Canadian Journal of Psychiatry 2006;51(8) supplement 2:3S-92S. p. 9S-17S, 19S-21S, 87S
Ciechanowski P, Katon W. (2010, September). Overview of generalized anxiety disorder. UpToDate Online. Available by subscription: www.uptodate.com
Swinson RP. Anxiety disorder. In: Gray J (Editor). Therapeutic choices. 5th ed. Ottawa, ON: Canadian Pharmacists Association; 2007. p. 11-26
Rowney J, Hermida T, Malone D. (2011).
Anxiety disorders. Cleveland Clinic Foundation. Box 5
McDade EM. (2010, September). Mild cognitive impairment: Epidemiology, pathology, and clinical assessment. UpToDate Online. Available by subscription: www.uptodate.com
Shadlen MF, Larson EB. (2010, September). Evaluation of cognitive impairment and dementia. UpToDate Online. Available by subscription: www.uptodate.com
Press D, Alexander M. (2010, September). Safety and societal issues related to dementia. UpToDate Online. Available by subscription: www.uptodate.com
Press D, Alexander M. (2010, September). Treatment of behavioral symptoms related to dementia. UpToDate Online. Available by subscription: www.uptodate.com
Chertkow H, Massoud F, Nasreddine Z, et al.
Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia. Canadian Medical Association Journal 2008;178(10):1273-85. p. 1275
Feldman HH, Jacova C, Robillard A, et al.
Diagnosis and treatment of dementia: 2. Diagnosis. Canadian Medical Association Journal 2008;178(7):825-36. p. 826
Registered Nurses Association of Ontario.
Screening for delirium, dementia and depression in older adults; Revised 2010. p. 23-34
Registered Nurses Association of Ontario.
Caregiving strategies for older adults with delirium, dementia and depression; Revised 2010. p. 48-66, 80, 141-175
Rockwood K, Chisholm T. Dementia. In: Gray J (Editor). Therapeutic choices. 5th ed. Ottawa, ON: Canadian Pharmacists Association; 2007. p. 43-59
Shadlen MF, Larson EB. (2010, September). Dementia syndromes. UpToDate Online. Available by subscription: www.uptodate.com
Shadlen MF, Larson EB. (2010, September). Risk factors for dementia.. UpToDate Online. Available by subscription: www.uptodate.com
Press D, Alexander M. (2010, September). Treatment of dementia. UpToDate Online. Available by subscription: www.uptodate.com
Hogan DB, Bailey P, Black S, et al.
Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia. Canadian Medical Association Journal 2008;179(10):1019-26. p. 1020-1022
Hogan DB, Bailey P, Black S, et al.
Diagnosis and treatment of dementia: 4. Approach to management of mild to moderate dementia. Canadian Medical Association Journal 2008;179(8):787-93. p. 789
McDade EM. (2010, September). Mild cognitive impairment: Prognosis and treatment. UpToDate Online. Available by subscription: www.uptodate.com
Fitzgerald MA. Nurse practitioner: Certification examination and practice preparation. 3rd ed. Philadelphia, PA: F.A. Davis Company; 2010. p. 277-278
Leik MTC. Family nurse practitioner certification intensive review: Fast facts & practice questions. New York: Springer Publishing Company; 2008. p. 261-262
Uphold C, Graham V. Clinical guidelines in family practice. 4th ed. Gainsville, FL: Barmarrae Books Inc.; 2003. p. 149-154
Harris R. (2010, September). Overview of preventive medicine in adults. UpToDate Online. Available by subscription: www.uptodate.com
Sillman JS. (2010, September). Diagnosing, screening, and counseling for domestic violence. UpToDate Online. Available by subscription: www.uptodate.com
MacMillan HL, Wathen CN with the Canadian Task Force on Preventive Health Care.
Prevention and treatment of violence against women: Systematic review & recommendations. CTFPHC Technical Report #01-4; 2001. London, ON: Canadian Task Force.
Francheck-Roa KM. (2010, September). Child witness to intimate partner violence. UpToDate Online. Available by subscription: www.uptodate.com
Cherniak D, Grant L, Mason R, et al.
SOGC clinical practice guidelines: Intimate partner violence consensus statement. JOGC 2005;157:365-88. p. 365-67
Registered Nurses Association of Ontario. Woman abuse: Screening, identification and initial response. Toronto, ON: Registered Nurses Association of Ontario; 2005. p. 17, 18, 20-31, 59-72, 79-83
Smith M, Segal J, Helpguide.org.
Domestic violence and abuse: Signs of abuse and abusive relationships; November 2010.
Waterloo Region Sexual Assault/Domestic Violence Treatment Centre. (2011).
Domestic violence.
Halphen JM, Dyer CB. (2010, September). Elder mistreatment: Abuse, neglect and financial exploitation. UpToDate Online. Available by subscription: www.uptodate.com
Filate W, Leung R, Ng D, Sinyor M. Essentials of clinical examination handbook. 5th ed. Toronto, ON: Medical Society, Faculty of Medicine, University of Toronto; 2005. p. 81-82
Smyer T, Graham MV. Mental health. In: Uphold C, Graham MV (Editors). Clinical guidelines in family practice. 4th ed. Gainsville, FL: Barmarrae Books Inc.; 2003. p. 149-154
Canadian Resource Centre for Victims of Crime.
Elder abuse; June 2006. p. 2
The Canadian Bar Association British Columbia Branch. (2011).
Family violence. What is family violence? section
Public Legal Education and Information Service of New Brunswick. (2009, May).
Publications: Abuse and violence. Defining the Problem section
Statistics Canada.
Family violence in Canada: A statistical profile. Catalogue no. 85-224-X. Ottawa, ON: Minister of Industry; January 2011. p. 13
Statistics Canada.
Family violence in Canada: A statistical profile. Catalogue no. 85-224-X. Ottawa, ON: Minister of Industry; January 2011. p. 14
Lupri E, Grandin E.
Intimate partner abuse against men. Ottawa, ON: National Clearinghouse on Family Violence; 2004.
British Columbia. (n.d.).
Signs of domestic violence.
Public Legal Education and Information Service of New Brunswick. (2009, May).
Publications: Abuse and violence. Getting Help section
MacMillan HL. (2000).
Preventive health care, 2000 update: Prevention of child maltreatment. Canadian Medical Association Journal;163(11):1451-56.
MacMillan HL, Wathen CN with the Canadian Task Force on Preventive Health Care.
Prevention and treatment of violence against women: Systematic review & recommendations. CTFPHC Technical Report #01-4; September, 2001. London, ON: Canadian Task Force.
Registered Nurses Association of Ontario. Woman abuse: Screening, identification and initial response. Toronto, ON: Registered Nurses Association of Ontario; 2005. p. 22-27
Rabin RF, Jennings JM, Campbell JC, Bair-Merritt MH.
Intimate partner violence screening tools: A systematic review. American Journal of Preventive Medicine 2009;36(5):439-45. p. 439
Public Legal Education and Information Service of New Brunswick. (2009, May).
Publications: Abuse and violence: Preventing abuse and neglect of seniors. Defining the Problem section
Public Legal Education and Information Service of New Brunswick. (2009).
Publications: Abuse and violence: A service provider's map to empowering women. Is woman abuse harmful? and How can the protocols help abused women become "empowered"? sections
Kelly R. (2010). Children's Aid Society of Ottawa-Carleton. Personal discussion regarding Reporting Maltreatment. April 14, 2010.
Indian and Northern Health Services. (1994, February 4). National child abuse protocol: Addressing legal issues for the health care team. Ottawa: Health Canada, Nursing Division, Medical Services. p. 8.
Finkelhor D, Hotaling G, Lewis IA, Smith C. (1990). Sexual abuse in a national survey of adult men and women: Prevalence, characteristics, and risk factors. Child Abuse and Neglect vol.14 p. 21
Endom EE. (2009, February 10). Child neglect and emotional abuse. UpToDate Online 17.2. Available by subscription: www.uptodate.com Child Neglect section.
Statistics Canada.
Family violence in Canada: A statistical profile. Catalogue no. 85-224-X. Ottawa, ON: Minister of Industry; January 2011. p. 10, 11, 15
Cherniak D, Grant L, Mason R, et al.
SOGC clinical practice guidelines: Intimate partner violence consensus statement. JOGC 2005;157:365-88. p. 372
Four Worlds Centre for Development Learning, Bopp M, Bopp J, Lane P.
Aboriginal domestic violence in Canada. Ottawa, ON: Aboriginal Healing Foundation; 2003. p. 26
Statistics Canada.
Family violence in Canada: A statistical profile. Catalogue no. 85-224-X. Ottawa, ON: Minister of Industry; January 2011. p. 10-11
Filate W, Leung R, Ng D, Sinyor M. Essentials of clinical examination handbook. 5th ed. Toronto, ON: Medical Society, Faculty of Medicine, University of Toronto; 2005. p. 81-82
Dumont-Smith C. (2002).
Aboriginal elder abuse in Canada.
Statistics Canada.
Family violence in Canada: A statistical profile. Catalogue no. 85-224-X. Ottawa, ON: Minister of Industry; January 2011. p. 28, 29
Canadian Resource Centre for Victims of Crime. (2006, June).
Elder abuse. p. 2
Dumont-Smith C. (2002).
Aboriginal elder abuse in Canada. p. 8
Canadian Mental Health Association.
Mood disorders; n.d.
Block SD. (2010, September). Grief and bereavement. UpToDate Online. Available by subscription: www.uptodate.com
Berger FK. (2010, Feb 14).
Adjustment disorder. A.D.A.M. PubMedHealth.
Reading J. (2009, March).
A life course approach to the social determinants of health for Aboriginal peoples'. p. A35-A36
Yatham LN, Kennedy SH, O'Donovan C, et al.
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disorders 2005;7(supplement 3):5-69. p.7-13, 20, 36-37, 41-42, 46-49
Institute for Clinical and Evaluative Science.
The bipolar express. Informed 2006;12(3):1-3. p. 1-3
Yatham LN, Kennedy SH, Schaffer A, et al.
Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disorders 2009;11: 225-255.
Parikh SV. Bipolar disorder. In: Gray J (Editor). Therapeutic choices. 5th ed. Ottawa, ON: Canadian Pharmacists Association; 2007. p. 78-96.
Dains JE, Baumann LC, Scheibel, P. Advanced health assessment and clinical diagnosis in primary care. 3rd ed. Philadelphia, PA: Mosby Elsevier; 2007. p. 455
Stovall J. (2010, September). Bipolar disorder: Epidemiology and diagnosis. UpToDate Online. Available by subscription: www.uptodate.com Clinical course section
Yatham LN, Kennedy SH, O'Donovan C, et al.
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disorders 2005;7(supplement 3): 5-69. p. 14
Stovall J. (2010, September). Using lithium to treat bipolar disorder in adults. UpToDate Online. Available by subscription: www.uptodate.com Laboratory tests and monitoring section
Piver A, Yatham LN, Lam RW.
Bipolar spectrum disorders: New perspectives. Canadian Family Physician 2002;48(5):896-904. p. 899
Parikh SV. Bipolar disorder. In: Gray J (Editor). Therapeutic choices. 5th ed. Ottawa, ON: Canadian Pharmacists Association; 2007. p. 84
Yatham LN, Kennedy SH, O'Donovan C, et al.
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. Bipolar Disorders 2006;8:729.
Stovall J. (2010, September). Using lithium to treat bipolar disorder in adults. UpToDate Online. Available by subscription: www.uptodate.com Laboratory tests and monitoring section
Yatham LN, Kennedy SH, O'Donovan C, et al.
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. Bipolar Disorders 2006;8:732.
Jensen PS, Cheung A, Zuckerbrot R, Ghalib K, Levitt A.
Guidelines for adolescent depression in Primary Care (GLAD-PC) Toolkit, version 1; 2007. Go to GLAD-PC Toolkit at bottom of page p. 10-84; 91-129
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. Journal of Affective Disorders 2009;117: 1-S64.
Kennedy SH, Parikh SV, Grigoriadis S. (2010, February). Psychiatric disorders: Depression. eTherapeutics. Available by subscription: http://www.e-therapeutics.ca
Registered Nurses Association of Ontario.
Nursing best practice guideline: Interventions for postpartum depression. Toronto, ON: Author; 2005. p. 20-36
Merrill DB. (2010, August 13).
Dysthymia. A.D.A.M. PubMedHealth.
Langenfeld SC. (2009, May 26).
Dysthymic disorder. eMedicine.
Schimelpfening N. (2011).
What is a major depressive episode?
Patten SB, Kennedy SH, Lam RW, et al.
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults: 1. Classification, burden and principles of management. Journal of Affective Disorders 2009;117:S5-S14. p. S5
First Nations Information Governance Centre. (2010).
Quick facts. Mental Health section
Mood Disorders Society of Canada.
Quick facts on mental illness and addictions in Canada. 2nd ed. 2007. p.16
Filate W, Leung R, Ng D, Sinyor M. Essentials of clinical examination handbook. 5th ed. Toronto, ON: Medical Society, Faculty of Medicine, University of Toronto; 2005. p. 273
Lyness JM. (2010, September). Clinical manifestations and diagnosis of depression. UpToDate Online. Available by subscription: www.uptodate.com Diagnosis section
Patten SB, Kennedy SH, Lam RW, et al.
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults: 1. Classification, burden and principles of management. Journal of Affective Disorders 2009;117:S5-S14. p.S8
Mood Disorders Society of Canada. (2009).
Quick facts: Mental illness and addiction in Canada. 3rd ed. p. 18
Canadian Psychiatric Association, Canadian Network for Mood and Anxiety Treatments. Clinical guidelines for the treatment of depressive disorders. Canadian Journal of Psychiatry 2001;46(Supplement 1). p. 63S-64S
Leik MTC. Family nurse practitioner certification intensive review: Fast facts & practice questions. New York: Springer Publishing; 2008. p. 256
Greenfield B.
Not just the teenage blues: Adolescent depression and suicidality. The Canadian Journal of Diagnosis 2003;4:90-97. p.91-94
Patten SB, Kennedy SH, Lam RW, et al.
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults: 1. Classification, burden and principles of management. Journal of Affective Disorders 2009;117: S5-S14. p. S10
Dains JE, Baumann LC, Scheibel, P. Advanced health assessment and clinical diagnosis in primary care. 3rd ed. Philadelphia, PA: Mosby Elsevier; 2007 p. 454
Baker LL, Ashbourne L, Steele M, Children's Mental Health Ontario. (2002).
Treating child and adolescent depression: A handbook for children's mental health practitioners. p.12, 80
Lam RW, Kennedy SH, Grigoriadis S, et al.
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults: III. Pharmacotherapy. Journal of Affective Disorders 2009;117:S26-S43. p. S27
Yatham LN, Kennedy SH, O'Donovan C, et al.
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of clients with bipolar disorder: consensus and controversies. Bipolar Disorders 2005;7(supplement 3):12.
Ryan-Wenger NA (Editor). Core curriculum for primary care pediatric nurse practitioners. St. Louis, MO: Mosby Elsevier; 2007. P.308-09
Canadian Psychiatric Association, Canadian Network for Mood and Anxiety Treatments. Clinical guidelines for the treatment of depressive disorders. Canadian Journal of Psychiatry 2001;46(Supplement 1). p. 22S
Patten SB, Kennedy SH, Lam RW, et al.
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults: 1. Classification, burden and principles of managment. Journal of Affective Disorders 2009;117:S5-S14. p.S11
Baker LL, Ashbourne L, Steele M, Children's Mental Health Ontario. (2002).
Treating child and adolescent depression: A handbook for children's mental health practitioners. p. 90
Baker LL, Ashbourne L, Steele M, Children's Mental Health Ontario. (2002).
Treating child and adolescent depression: A handbook for children's mental health practitioners. p. 86
Ravindran AV, Lam RW, Filteau MJ, et al.
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults: V. Complementary and alternative medicine treatments. Journal of Affective Disorders 2009;117:S54-S64. p. S55-S58
Lyness JM. (2010, September). Clinical manifestations and diagnosis of depression. UpToDate Online. Available; http://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-depression?source=search_result&selectedTitle=3%7E29 Clinical presentation section
Parikh SV, Segal ZV, Grigoriadis S, et al.
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults: II. Psychotherapy alone or in combination with antidepressant medication. Journal of Affective Disorders 2009;117:S15-S25. p. S15, S22
Parikh SV, Segal ZV, Grigoriadis S, et al.
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults: II. Psychotherapy alone or in combination with antidepressant medication. Journal of Affective Disorders 2009; 117: S15-S25. p. S21
McNaughton JL.
Brief interventions for depression in primary care: A systematic review. Canadian Family Physician 2009;55:789-96. p. 795-96
Lam RW, Kennedy SH, Grigoriadis S, et al.
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults: III. Pharmacotherapy. Journal of Affective Disorders 2009;117:S26-S43. p.S27- S28, S35, S38
Lam RW, Kennedy SH, Grigoriadis S, et al.
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults: III. Pharmacotherapy. Journal of Affective Disorders 2009;117:S26-S43. p. S27
Kennedy SH, Parikh SV, Grigoriadis S.(2010, February). Psychiatric disorders: Depression. eTherapeutics. Available by subscription: http://www.e-therapeutics.ca
Lam RW, Kennedy SH, Grigoriadis S, et al.
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults: III. Pharmacotherapy. Journal of Affective Disorders 2009;117: S26-S43. p.S33-S35
Ontario Problem Gambling Research Centre. (2010).
Problem Gambling Framework. All sections
Centre for Addiction and Mental health. (2008).
Problem gambling: A guide for helping professionals. p. 12, 16-18, 25-33
Tremblay J, Stinchfield R, Wiebe J, Wynne H. (2010, July).
Canadian Adolescent Gambling Inventory: Phase III Final Report. p. 52
Centre for Addictions and Mental Health. (2006).
Adolescent mental health, resilience and Ontario data. Ontario data on students' mental health and wellbeing section
Centre for Addiction and Mental health. (2008).
Problem gambling: A guide for helping professionals. p. 17
Mood Disorders Society of Canada. (2007).
Quick facts on mental illness and addictions in Canada. 2nd ed. 2007: p. 25-26
Gupta R, Derevensky JL. Adolescent gambling behavior : A prevalence study and examination of the correlates associated with problem gambling. Journal of Gambling Studies 1998;14(4):319-45.
Tremblay J, Stinchfield R, Wiebe J, Wynne H. (2010, July).
Canadian adolescent gambling inventory: Phase III final report. p. 9, 53-55
Ferris J, Wynne H. (2001, February 19).
Canadian problem gambling index: Final report.
Centre for Addiction and Mental Health. (2011).
Clinical tools: Problem gambling.
Mood Disorders Society of Canada. (2007).
Quick facts on mental illness and addictions in Canada. 2nd ed. p. 26
McCormick R, Russo A, Ramirez L, Taber J.
Affective disorders among pathological gamblers seeking treatment. American Journal of Psychiatry 1984;141(2):215-18.
Beaudoin C, Cox B.
Characteristics of problem gambling in a Canadian context: A preliminary study using a DSM-IV-based questionnaire. Canadian Journal of Psychiatry 1999;44(5):483-87.
Centre for Addictions and Mental Health. (2011).
Helping professionals: Part I : Problem gambling assessment and screening for physicians.
Ministry of Health, British Columbia. (2000).
Early identification of psychosis: A primer.
Canadian Psychiatric Association.
Clinical practice guidelines for schizophrenia. Canadian Journal of Psychiatry 2005;50(13 supplement 1):1S-56S. p. 7S, 11S-43S
Filate W, Leung R, Ng D, Sinyor M. Essentials of clinical examination handbook. 5th ed. Toronto, ON: Medical Society, Faculty of Medicine, University of Toronto; 2005. p. 275-76
Milliken H. (2009, November). Psychiatric disorders: Psychoses. eTherapeutics. Available by subscription: http://www.e-therapeutics.ca
Jibson MD. (2010, September). Schizophrenia: Clinical presentation, epidemiology, and pathophysiology. UpToDate Online. Available by subscription: www.uptodate.com
Jibson MD. (2010, September). Schizophrenia: Diagnostic evaluation and treatment. UpToDate Online. Available by subscription: www.uptodate.com
National Institute for Health and Clinical Excellence.
Schizophrenia: Core interventions in the treatment and management of schizophrenia in adults in primary and secondary care. NICE clinical guideline 82. London, England: Author; 2009. p. 4-34
Registered Nurses Association of Ontario.
Nursing best practice guideline: Crisis intervention. Toronto, ON: Author; 2006. p. 14-31, 43-53
Registered Nurses Association of Ontario.
Nursing best practice guideline: Crisis intervention. Toronto, ON: Author; 2006. p. 50-52
Registered Nurses Association of Ontario.
Nursing best practice guideline: Crisis intervention. Toronto, ON: Author; 2006. p. 22
Registered Nurses Association of Ontario.
Nursing best practice guideline: Crisis intervention. Toronto, ON: Author; 2006. p. 28
Public Health Agency of Canada.
Sexual assault in postpubertal adolescents and adults. Canadian guidelines on sexually transmitted infections. Ottawa, ON: Author; 2010, January.
Bates CK. (2010, September). Evaluation and management of sexual assault victims. UpToDate Online. Available by subscription: www.uptodate.com
Society of Obstetricians and Gynaecologists of Canada.
Sexual health: Sexual assault. Ottawa, ON: Author; 2010.
Bates CK, Lewis-O'Connor A. (2010, September). Patient information: Care after sexual assault. UpToDate Online. Available by subscription: www.uptodate.com
Public Legal Education and Information Service of New Brunswick. (2009, May).
Publications: Abuse and violence. Defining the Problem section
Society of Obstetricians and Gynaecologists of Canada.
Drug facilitated sexual assault. Ottawa, ON: Author; 2010.
Society of Obstetricians and Gynaecologists of Canada.
Sexual assault: The law. Ottawa, ON: Author; 2010.
Fredericton Sexual Assault Crisis Centre. (2010).
Sexual assault statistics. What percentage of Canadian women are victims of sexual violence section
Public Health Agency of Canada.
Sexual assault in postpubertal adolescents and adults. Canadian guidelines on sexually transmitted infections. Ottawa, ON: Author; 2010, January. p. 1
Brennan S, Taylor-Butts A.
Sexual assault in Canada 2004 and 2007. Ottawa, ON: Canadian Centre for Justice Statistics; 2008, December. p. 6
Brennan S, Taylor-Butts A.
Sexual assault in Canada 2004 and 2007. Ottawa, ON: Canadian Centre for Justice Statistics; 2008, December. p. 14
Brennan S, Taylor-Butts A.
Sexual assault in Canada 2004 and 2007. Ottawa, ON: Canadian Centre for Justice Statistics; 2008, December. p. 13
Fredericton Sexual Assault Crisis Centre. (2011).
Sexual assault statistics. What circumstances surround sexual assault section
Fredericton Sexual Assault Crisis Centre. (2011).
Sexual assault statistics. What happens when a woman resists section
Fredericton Sexual Assault Crisis Centre. (2011).
Sexual assault statistics. Who is more likely to experience sexual assault section
Centre for Addiction and Mental Health. (n.d.)
Mental health and addiction 101 series: Introduction to addiction webinar. All sections
Humeniuk RE, Henry-Edwards S, Ali RL, Poznyak V, Monteiro M.
The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): manual for use in primary care. Geneva: World Health Organization; 2010. p. 2, 3, 8-53
Weaver MF, Jarvis MAE. (2011, January). Overview of the recognition and management of the drug abuser. UpToDate Online. Available by subscription: www.uptodate.com
Chansonneuve D.
Addictive behaviours among Aboriginal people in Canada. Ottawa, ON: Aboriginal Health Foundation; 2007. p. 31
Mayo Clinic Staff. (2009).
Drug addiction: Symptoms. First paragrap
Sochting I, Corrado R, Cohen IM, et al.
Traumatic pasts in Canadian Aboriginal people: Further support for a complex trauma conceptualization? BCMJ 2007;49(6):320-26. Table 4
Jensen B, Regier L. (Editors). RxFiles: Drug comparison charts. 8th ed. Saskatoon, SK: Saskatoon Health Region; 2010, October. p. 124 Statistics from the literature section
Addiction issues: Addiction risk screening. (n.d.). Screening for other risk factors section
Opioid risk tool score sheet. (n.d.).
Centre for Addiction and Mental Health. (2008).
Educating students about drug use and mental health - Risk and protective factors: Youth and substance abuse. Individual and Interpersonal sections
Goldenring JM, Rosen DS.
Getting into adolescent heads: An essential update. Contemporary Pediatrics 2004;21(1):64-90. p. 67, 76, 79
Mayo Clinic Staff. (2009).
Drug addiction: Symptoms. First 2 paragraphs and Recognizing drug abuse in teenagers sections
Humeniuk RE, Henry-Edwards S, Ali RL, Poznyak V, Monteiro M.
The ASSIST-linked brief intervention for hazardous and harmful substance use: manual for use in primary care. Geneva: World Health Organization; 2010. p. 27
Ryan-Wenger NA (Editor). Core curriculum for primary care pediatric nurse practitioners. St. Louis, MO: Mosby Elsevier; 2007. p. 342
Addiction issues: Addiction risk screening. (n.d.). The CAGE questions section
Mayo Clinic Staff. (2009).
Drug addiction: Symptoms. Recognizing signs of drug use and dependence section
Chansonneuve D.
Addictive behaviours among Aboriginal people in Canada. Ottawa, ON: Aboriginal Health Foundation; 2007.p. 79
Centre for Addiction and Mental Health. (2008).
About marijuana. What is marijuana? and How does marijuana make you feel sections
Centre for Addiction and Mental Health. (2010).
Do you know… cannabis. How does cannibis make you feel? section
Centre for Addiction and Mental Health. (2010).
Do you know… inhalants. What are inhalants? and How do inhalants make you feel? sections
Centre for Addiction and Mental Health. (2008).
Do you know… amphetamines. How to amphetamines make you feel? section
Centre for Addiction and Mental Health. (2010).
Do you know… hallucinogens. How do hallucinogens make you feel? section
Centre for Addiction and Mental Health. (2010).
Do you know… caffeine. How does caffeine make you feel? section
Centre for Addiction and Mental Health. (2009).
Do you know… cocaine. How does cocaine make you feel? section
Centre for Addiction and Mental Health. (2008).
Do you know… methamphetamine. How does methamphetamine make you feel? section
Centre for Addiction and Mental Health. (2010).
Do you know… hallucinogens. .How do hallucinogens make you feel? section
Centre for Addiction and Mental Health. (2008).
Do you know… ketamine. How does ketamine make you feel? section
Centre for Addiction and Mental Health. (2010).
Do you know… LSD. How does LSD make you feel? section
Greig A, Constantin E, Carsley S, Cummings C, Canadian Paediatric Society Community Paediatrics Committee.
Preventive health care visits for children and adolescents aged 6 to 17 years: The Greig Health Record - technical report. Paediatrics and Child Health 2010;15(3):157-59.
Mayo Clinic. (2009).
Teen drinking: Talking to your teen about alcohol. Consequences of teen drinking section
Centre for Addiction and Mental Health. (2009).
Do you know… cocaine. Is cocaine dangerous section
Centre for Addiction and Mental Health. (2010).
About alcohol. The dangers and the law section
Mood Disorders Society of Canada. (2007).
Quick facts on mental illness and addictions in Canada. 2nd ed. p. 33
Ryan-Wenger NA (Editor). Core curriculum for primary care pediatric nurse practitioners. St. Louis, MO: Mosby Elsevier; 2007. p. 345-46
Gold MS, Aronson MD. (2011, January). Psychosocial treatment of alcohol abuse and dependence. UpToDate Online. Available by subscription: www.uptodate.com Presenting the diagnosis section
Goldenring JM, Rosen DS.
Getting into adolescent heads: An essential update. Contemporary Pediatrics 2004;21(1):64-90 p. 79
Humeniuk RE, Henry-Edwards S, Ali RL, Poznyak V, Monteiro M.
The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): manual for use in primary care. Geneva: World Health Organization; 2010. p. 35-36
Humeniuk RE, Henry-Edwards S, Ali RL, Poznyak V, Monteiro M.
The ASSIST-linked brief intervention for hazardous and harmful substance use: manual for use in primary care. Geneva: World Health Organization; 2010. p. 1-38
Ryan-Wenger NA (Editor). Core curriculum for primary care pediatric nurse practitioners. St. Louis, MO: Mosby Elsevier; 2007. p. 344
Weaver MF, Jarvis MAE. (2011, January). Overview of the recognition and management of the drug abuser. UpToDate Online. Available by subscription: www.uptodate.com Long term treatment section, first paragraph
Humeniuk RE, Henry-Edwards S, Ali RL, Poznyak V, Monteiro M.
The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): manual for use in primary care. Geneva: World Health Organization; 2010. p. 36
Gold MS, Aronson MD. (2011, January). Screening for alcohol misuse. UpToDate Online. Available by subscription: www.uptodate.com
Gold MS, Aronson MD. (2011, January). Alcohol abuse and dependence: Epidemiology, clinical manifestations and diagnosis. UpToDate Online. Available by subscription: www.uptodate.com
Cowan E, Su M. (2011, January). Ethanol intoxication in adults. UpToDate Online. Available by subscription: www.uptodate.com
Moses S. (2010).
Alcohol abuse DSM-IV criteria. Section II
Mood Disorders Society of Canada. (2007).
Quick facts on mental illness and addictions in Canada. 2nd ed. p.18, 33
First Nations Information Governance Centre. (2010).
Quick facts. Drug and Alcohol Use section
Carson G, Cos LV, Crane J, Croteau P, et al.
Alcohol use and pregnancy consensus clinical guidelines. Journal of Obstetrics and Gynaecology Canada 2010:32(8 Supplement 3):S1-S32. p. S20
Mood Disorders Society of Canada. (2007).
Quick facts on mental illness and addictions in Canada. 2nd ed. p. 25
Carson G, Cos LV, Crane J, Croteau P, et al.
Alcohol use and pregnancy consensus clinical guidelines. Journal of Obstetrics and Gynaecology Canada 2010:32(8 Supplement 3):S1-S32. p. S8
Canadian Paediatric Society.
Fetal alcohol syndrome. Paediatric & Child Health 2002;7(3):161-74. p. 161
Cowan E, Su M. (2011, January). Ethanol intoxication in adults. UpToDate Online. Available by subscription: www.uptodate.com Pathophysiology section
Gold MS, Aronson MD. (2011, January). Alcohol abuse and dependence: Epidemiology, clinical manifestations, and diagnosis..UpToDate Online. Available by subscription: www.uptodate.com Epidemiology and Risk Factors: Adult section
Carson G, Cos LV, Crane J, Croteau P, et al.
Alcohol use and pregnancy consensus clinical guidelines. Journal of Obstetrics and Gynaecology Canada 2010:32(8 Supplement 3):S1-S32. p. S21
Carson G, Cos LV, Crane J, Croteau P, et al.
Alcohol use and pregnancy consensus clinical guidelines. Journal of Obstetrics and Gynaecology Canada 2010:32(8 Supplement 3):S1-S32. p. S1
Gold MS, Aronson MD. (2011, January). Screening for alcohol misuse. UpToDate Online. Available by subscription: www.uptodate.com Single question screening section
Mood Disorders Society of Canada. (2007).
Quick facts on mental illness and addictions in Canada. 2nd ed. p.31
Humeniuk RE, Henry-Edwards S, Ali RL, Poznyak V, Monteiro M.
The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): manual for use in primary care. Geneva: World Health Organization; 2010. p. 12
Mukamal KJ. (2011, January). Overview of the risks and benefits of alcohol consumption. UpToDate Online. Available by subscription: www.uptodate.com
Gold MS, Aronson MD. (2011, January). Psychosocial treatment of alcohol abuse and dependence. UpToDate Online. Available by subscription: www.uptodate.com
Johnson BA. (2011, January). Pharmacologic treatment of alcohol abuse and dependence. UpToDate Online. Available by subscription: www.uptodate.com
Cowan E, Su M. (2011, January). Ethanol intoxication in adults. UpToDate Online. Available by subscription: www.uptodate.com
Hoffman RS, Weinhouse GL. (2011, January). Management of moderate and severe alcohol withdrawal syndromes. UpToDate Online. Available by subscription: www.uptodate.com
Volpicelli JR, Teitelbaum SA. (2011, January). Ambulatory alcohol detoxification. UpToDate Online. Available by subscription: www.uptodate.com
Kennedy JR. (2009, April). Psychiatric disorders: Drug withdrawal syndromes. eTherapeutics. Available by subscription: http://www.e-therapeutics.ca
Baynard, M, Mcintyre J, Hill KR, Woodside J.
Alcohol withdrawal syndrome. American Family Physician 2004;69(6):1443-50. Table 1 section
Centre for Addiction and Mental Health (2008).
About marijuana. Who uses cannabis, What are the long term effects of using cannabis, and Is cannabis addictive sections
Bailey JA, DuPont RL, Teitelbaum SA. (2011, January). Cannabis (marijuana) use disorders: Epidemiology, comorbidity, and pathogenesis. UpToDate Online. Available by subscription: www.uptodate.com
DuPont RL, Bailey JA, Teitelbaum SA. (2011, January). Cannabis (marijuana) use disorders: Clinical features and diagnosis. UpToDate Online. Available by subscription: www.uptodate.com
Teitelbaum SA, DuPont RL, Bailey JA. (2011, January). Cannabis (marijuana) use disorders: Treatment, prognosis and long term medical effects. UpToDate Online. Available by subscription: www.uptodate.com
Clark AJ, Lynch ME, Ware M, et al.
Guidelines for the use of cannabinoid compounds in chronic pain. Pain Research & Management 2005;10(Supplement A):44A-46A. p. 44A-45A
Ryan-Wenger NA (Editor). Core curriculum for primary care pediatric nurse practitioners. St. Louis, MO: Mosby Elsevier; 2007. p. 342
Bailey JA, DuPont RL, Teitelbaum SA. (2011, January). Cannabis (marijuana) use disorders: Epidemiology, comorbidity, and pathogenesis. UpToDate Online. Available by subscription: www.uptodate.com Cannabis dependence section
Humeniuk RE, Henry-Edwards S, Ali RL, Poznyak V, Monteiro M.
The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): manual for use in primary care. Geneva: World Health Organization; 2010. p.13
Registered Nurses Association of Ontario.
Integrating smoking cessation into daily nursing practice. Toronto, ON: Author; 2007, March. p. 19-33, 56-82
Centre for Addiction and Mental Health. (2010).
About tobacco. The dangers and the law section
CAN-ADAPTT's Clinical Practice Guideline Development Group, Cote-Meek S.
CAN ADAPTT Canadian smoking cessation guideline: Specific populations: Aboriginal peoples. Toronto, ON: Centre for Addiction and Mental Health; 2010, November 22.
Sackey JA. (2011, January). Smoking cessation counseling strategies in primary care. UpToDate Online. Available by subscription: www.uptodate.com
Jensen B, Regier L. (Editors). RxFiles: Drug comparison charts. 8th ed. Saskatoon, SK: Saskatoon Health Region; 2010, October. p. 115
Selby P. Smoking cessation. In: Gray J (Editor). Therapeutic choices. 5th ed. Ottawa, ON: Canadian Pharmacists Association; 2007. p. 146-57.
Centre for Addiction and Mental Health. (2010).
About tobacco. Second paragraph and Did you know, Fast Facts and Different forms of tobacco sections
Rubenfire M, Jackson E. (2011, January). Cardiovascular risk of smoking and benefits of smoking cessation. UpToDate Online. Available by subscription: www.uptodate.com
Rennard SI, Rigotti NA, Daughton DM. (2011, January). Management of smoking cessation in adults. UpToDate Online. Available by subscription: www.uptodate.com
Chansonneuve D.
Addictive behaviours among Aboriginal people in Canada. Ottawa, ON: Aboriginal Health Foundation; 2007. p. 26
First Nations Information Governance Centre. (2010).
Quick facts. Smoking and Tobacco Use section
Rigotti NA, Rennard SI, Daughton DM. (2011, January). Patterns of tobacco use and benefits of smoking cessation. UpToDate Online. Available by subscription: www.uptodate.com
Humeniuk RE, Henry-Edwards S, Ali RL, Poznyak V, Monteiro M.
The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): manual for use in primary care. Geneva: World Health Organization; 2010. p.11
University of Ottawa Heart Institute.
Program summary: An evidence-based, systematic approach to addressing tobacco use in primary care clinics. Ottawa, ON: Author; n.d.
CAN-ADAPTT's Clinical Practice Guideline Development Group, Ordean A.
CAN ADAPTT Canadian smoking cessation guideline: Specific populations: Pregnant and breastfeeding women. Toronto, ON: Centre for Addiction and Mental Health; 2010, November 24.
CAN-ADAPTT's Clinical Practice Guideline Development Group, Brosky G.
CAN-ADAPTT Canadian smoking cessation guideline: Counselling and psychosocial approaches. Toronto, ON: Centre for Addiction and Mental Health; 2011, February 2.
CAN-ADAPTT's Clinical Practice Guideline Development Group, O'Loughlin J.
CAN ADAPTT Canadian smoking cessation guideline: Specific populations: Youth (children and adolescents). Toronto, ON: Centre for Addiction and Mental Health; 2010, November 30.
Rosen JB, Sockrider M. (2011, January). Management of smoking cessation in adolescents. UpToDate Online. Available by subscription: www.uptodate.com
Wong SK, First Nations, Inuit and Metis Health Committee.
Use and misuse of tobacco among Aboriginal peoples. Paediatric and Child Health 2006;11(10):681-85. Addressing the problem of high tobacco use section
Health Canada. Help on quitting smoking. Ottawa, ON: Author; 2008.
Champlain CVD Prevention Network. (2010).
Ottawa model for smoking cessation. Why does our program work section
Health Canada. Non-Insured Health Benefits First Nations Inuit Health Branch: Drug benefit list. Ottawa, ON: Author; 2010.
Wong SK, First Nations, Inuit and Métis Health Committee.
Use and misuse of tobacco among Aboriginal peoples. Paediatric and Child Health 2006;11(10):681-685. Summary and Recommendations sections
Centre for Addiction and Mental Health. (2010).
About tobacco. The dangers and the law and How can I reduce my risks sections
Weaver MF, Jarvis MAE. (2011, January). Overview of the recognition and management of the drug abuser. UpToDate Online. Available by subscription: www.uptodate.com
Parran TV, Wilford BB, DuPont R. (2011, January). Prescription drug abuse and addiction: Clinical features, epidemiology, and contributing factors. UpToDate Online. Available by subscription: www.uptodate.com
Wilford BB, Parran TV, DuPont RL. (2011, January). Prescription drug abuse and addiction: Prevention, identification, and management. UpToDate Online. Available by subscription: www.uptodate.com
Kennedy JR. (2009, April). Psychiatric disorders: Drug withdrawal syndromes. eTherapeutics. Available by subscription: http://www.e-therapeutics.ca
Young L. Generation rx:
Taking action on teen prescription drug abuse. Crosscurrents 2008. Paragraphs 3, 4, 7, 10
National Institute of Drug Abuse. (n.d.).
Prescription medications. Brief description section
Ontario Ministry of Health and Long term Care. (2010). Narcotics Strategy. Ontario's plan to reduce the misuse and abuse of prescription narcotics and other controlled substances. p. 4
Fitzgerald MA. Nurse practitioner: Certification examination and practice preparation. 3rd ed. Philadelphia, PA: F.A. Davis Company; 2010. p. 259
Mayo Clinic Staff. (2010).
Prescription drug abuse: Causes. Causes section
Mayo Clinic Staff. (2010).
Prescription drug abuse: Symptoms. Prescription drug abuse symptoms section
National Institute of Drug Abuse. (n.d.).
Preventing and recognizing prescription drug abuse. Role of health care providers section
Jensen B, Regier L (Editors). RxFiles: Drug comparison charts. 8th ed. Saskatoon, SK: Saskatoon Health Region; 2010, October. p. 125
Fitzgerald MA. Nurse practitioner: Certification examination and practice preparation. 3rd ed. Philadelphia, PA: F.A. Davis Company; 2010. p. 262
Norman TR, Ellen SR, Burrows GD. Benzodiazepines in anxiety disorders: Managing therapeutics and dependence. Medical Journal of Australia 1998.
Weaver MF, Hopper JA. (2011, January). Opioid abuse and dependence: Overview and patient evaluation. UpToDate Online. Available by subscription: www.uptodate.com Consequences of abuse section
Mayo Clinic Staff. (2010).
Prescription drug abuse: Treatments and drugs. Entire page
Mayo Clinic Staff. (2010).
Prescription drug abuse: Coping and support. First paragraph
Vergare MJ, Binder RL, et al. (2006). Psychiatric Evaluation of Adults, Second Edition. Available at: http://psychiatryonline.org/content.aspx?bookid=28§ionid=2021669#137733)
Hoffman RS, Weinhouse GL. (2011, January). Management of moderate and severe alcohol withdrawal syndromes. UpToDate Online. Available by subscription: www.uptodate.com
Volpicelli JR, Teitelbaum SA. (2011, January). Ambulatory alcohol detoxification. UpToDate Online. Available by subscription: www.uptodate.com
Yim A. (2009, October). Delirium tremens in emergency medicine. eMedicine. [HYPERLINK TO: http://emedicine.medscape.com/article/791802-overview#showall]
Francis Jr J, Young GJ. (2010, September). Diagnosis of delirium and confusional states. UpToDate Online. Available by subscription: www.uptodate.com
Francis Jr J. (2010, September). Prevention and treatment of delirium and confusional states. UpToDate Online. Available by subscription: www.uptodate.com
Registered Nurses Association of Ontario.
Screening for delirium, dementia and depression in older adults; Revised 2010. p. 23-34
Registered Nurses Association of Ontario.
Caregiving strategies for older adults with delirium, dementia and depression; Revised 2010. p. 32, 34-44
Library of Parliament. (2003).
Teen suicide in Canada. p.1-2, 7-9, 11-12, Appendix A
Registered Nurses Association of Ontario.
Best practice guideline: Assessment and care of adults at risk for suicidal ideation and behaviour. Toronto, ON: Author; 2009. p. 18-57, 94-105
Bilsker D, Samra J.
Working with the suicidal patient: A guide for health care professionals. Vancouver, BC: Consortium for Organizational Mental Health; 2007.
Schreiber J, Culpepper L, Fife A. (2010, September). Suicidal ideation and behavior in adults. UpToDate Online. Available by subscription: www.uptodate.com
Gliatto MF, Rai AK.
Evaluation and treatment of clients with suicidal ideation. American Family Physician 1999, March 15. Second paragraph
Kirmayer LJ, Brass GM, Holton T, et al.
Suicide among aboriginal people in Canada. Ottawa, ON: Aboriginal Healing Foundation; 2007. p. 3
Clarke DR, Brown A-M, Giles-Smith L. Triaging suicidal patients: Sifting through the evidence. International Emergency Nursing 2008; 16: 165-174.
Mood Disorders Society of Canada. (2007).
Quick facts on mental illness and addictions in Canada. 2nd ed. p.17
Health Canada. (2005).
A statistical profile on the health of First Nations in Canada for the year 2000.
Health Canada.
Departmental performance report: 2009-2010. p. 15
Furi M, Guimont M. Teen suicide in Canada. Library of Parliament. Ottawa: Government of Canada; 2003. Available from http://publications.gc.ca/collections/Collection-R/LoPBdP/PRB-e/PRB0342-e.pdf
First Nations Information Governance Centre. (2010).
Quick facts. Mental Health section
Schreiber J, Culpepper L, Fife A. (2010, September). Suicidal ideation and behavior in adults. UpToDate Online. Available by subscription: www.uptodate.com Epidemiology section
Gideon V, Gray J, Nicholas W, Ha P.
First Nations youth health: Recognizing the challenges, recognizing the potential. Horizons 2008;10(1):83-87. p. 84
Kirmayer LJ, Brass GM, Holton T, et al.
Suicide among aboriginal people in Canada. Ottawa, ON: Aboriginal Healing Foundation; 2007. p. 30
White J, Jodoin N. Aboriginal Youth: A manual of promising suicide prevention strategies. Calgary, AB: Centre for Suicide Prevention; 2007. p.12, 16, 18, 19, 266-274
Kirmayer LJ, Brass GM, Holton T, et al.
Suicide among aboriginal people in Canada. Ottawa, ON: Aboriginal Healing Foundation; 2007. p. 34-54
Kirmayer LJ, Boothroyd LJ, Laliberte A, Simpson BL.
Native Mental Health Research Team: Suicide prevention and mental health promotion in First Nations and Inuit communities. Culture and Mental Health Research Unit Report No. 9; 1999. p. 13
Clarke DR, Brown A-M, Giles-Smith L. Triaging suicidal patients: Sifting through the evidence. International Emergency Nursing 2008; 16: 165-174.
Gliatto MF, Rai AK.
Evaluation and treatment of clients with suicidal ideation. American Family Physician 1999, March 15. Synthesis section, first paragraph
White J, Jodoin N.
Aboriginal Youth: A manual of promising suicide prevention strategies. Calgary, AB: Centre for Suicide Prevention; 2007. p.12, 16, 18, 19, 266-274
Kirmayer LJ, Brass GM, Holton T, et al.
Suicide among aboriginal people in Canada. Ottawa, ON: Aboriginal Healing Foundation; 2007. p. 34-54
Kirmayer LJ, Boothroyd LJ, Laliberte A, Simpson BL.
Native Mental Health Research Team: Suicide prevention and mental health promotion in First Nations and Inuit communities. Culture and Mental Health Research Unit Report No. 9; 1999. p. 14
Registered Nurses Association of Ontario (RNAO) (2009) Assessment and care of adults at risk for suicidal ideation and behaviour. Page 30. Available at: http://www.rnao.org/Storage/58/5263_Sucide_-Final-web.pdf
Baker LL, Ashbourne L, Steele M, Children's Mental Health Ontario.
Treating child and adolescent depression: A handbook for children's mental health practitioners; 2002. p. 21, 123-130
Jensen PS, Cheung A, Zuckerbrot R, Ghalib K, Levitt A.
Guidelines for Adolescent Depression in Primary Care (GLAD-PC) Toolkit, version 1; 2007. Go to GLAD-PC Toolkit at bottom of page p. 95
Gask L, Morriss R. Assessment and immediate management of people at risk of harming themselves. The Foundation Years 2008; 4(2): 64-8. Available at: http://www.sciencedirect.com/science/article/pii/S174418890800008X
Registered Nurses Association of Ontario.
Nursing best practice guideline: Crisis intervention. Toronto, ON: Author; 2006. p. 30
Gliatto MF, Rai AK.
Evaluation and treatment of clients with suicidal ideation. American Family Physician 1999, March 15. Outpatient treatment section, first paragraph
Registered Nurses Association of Ontario.
Nursing best practice guideline: Crisis intervention. Toronto, ON: Author; 2006. p. 50-52
Gliatto MF, Rai AK.
Evaluation and treatment of clients with suicidal ideation. American Family Physician 1999, March 15. Outpatient treatment section, third paragraph
Baker LL, Ashbourne L, Steele M, Children's Mental Health Ontario. (2002).
Treating child and adolescent depression: A handbook for children's mental health practitioners. p. 24, 131-135
Bilsker D, Samra J.
Working with the suicidal patient: A guide for health care professionals. Vancouver, BC: Consortium for Organizational Mental Health; 2007. p. 4
Registered Nurses Association of Ontario.
Nursing best practice guideline: Crisis intervention. Toronto, ON: Author; 2006. p. 22
Ryan-Wenger NA (Editor). Core curriculum for primary care pediatric nurse practitioners. St. Louis, MO: Mosby Elsevier; 2007. p. 122
Giordano R, Stichler J. (2009). Improving Suicide Risk Assessment in the Emergency Department. Journal of Emergency Nursing 35 (1) ; pp 22-26
Gliatto MF, Rai AK. Evaluation and treatment of clients with suicidal ideation. American Family Physician 1999, March 15. [HYPERLINK TO: www.aafp.org/afp/990315ap/1500.html] Outpatient treatment section, first, second, third, and fourth paragraphs
Canadian Mental Health Association. (2010).
Grief after suicide. All sections of the page
Kirmayer LJ, Brass GM, Holton T, et al.
Suicide among aboriginal people in Canada. Ottawa, ON: Aboriginal Healing Foundation; 2007. p. 32
Ryan-Wenger NA (Editor). Core curriculum for primary care pediatric nurse practitioners. St. Louis, MO: Mosby Elsevier; 2007. p. 210
Gliatto MF, Rai AK.
Evaluation and treatment of clients with suicidal ideation. American Family Physician 1999, March 15. Outpatient treatment section, third, and fourth paragraphs
Registered Nurses Association of Ontario.
Nursing best practice guideline: Crisis intervention. Toronto, ON: Author; 2006. p. 28
White J, Jodoin N.
Aboriginal Youth: A manual of promising suicide prevention strategies. Calgary, AB: Centre for Suicide Prevention; 2007. p. 27
Kirmayer LJ, Brass GM, Holton T, et al.
Suicide among aboriginal people in Canada. Ottawa, ON: Aboriginal Healing Foundation; 2007. p. 81-96
Canadian Paediatric Society.
Youth and firearms in Canada. Paediatric and Child Health 2005;10(8): 473-77. p. 475-76
Moore G, Pfaff JA. (2010, September). Assessment and management of the acutely agitated or violent client. UpToDate Online. Available by subscription: www.uptodate.com
National Collaborating Centre for Nursing and Supportive Care.
Violence: The short term management of disturbed/violent behaviour in in-patient psychiatric settings and emergency departments: Clinical guideline 25. London, England: National Institute for Clinical Excellence; 2005, February.
Canadian Psychiatric Association.
Clinical practice guidelines for schizophrenia. Canadian Journal of Psychiatry 2005;50(13 supplement 1):1S-56S. p. 20S-21S
Registered Nurses Association of Ontario.
Nursing best practice guideline: Crisis intervention. Toronto, ON: Author; 2006. p. 18-31
Skakum K, Reiss JP. Acute agitation. In: Gray J (Editor). Therapeutic choices. 5th ed. Ottawa, ON: Canadian Pharmacists Association; 2007. p. 1-10
Mood Disorders Society of Canada. (2007).
Quick facts on mental illness and addictions in Canada. 2nd ed. p. 5, 14-15
Rocca P., et al.(2006). Managing the aggressive and violent patient in the psychiatric emergency, Progress in Neuro-Psychopharmacology & Biological Psychiatry 30 pp.586-598. Available at : http://pdn.sciencedirect.com/science?_ob=MiamiImageURL&_cid=271215&_user=605159&_pii=S0278584606000376&_check=y&_origin=article&_zone=toolbar&_coverDate=30-Jun-2006&view=c&originContentFamily=serial&wchp=dGLzVlt-zSkzk&md5=5b6c81293b9da7b22a0041c7b9c5d1db/1-s2.0-S0278584606000376-main.pdf
Petit JR. Handbook of Emergency Psychiatry. Philadelphia: Lippincott Williams and Wilkins; 2004.
Registered Nurses Association of Ontario.
Nursing best practice guideline: Crisis intervention. Toronto, ON: Author; 2006; p 10.
Registered Nurses Association of Ontario.
Nursing best practice guideline: Crisis intervention. Toronto, ON: Author; 2006. p. 22